R. Elkon, A. P. Ugalde, and R. Agami, Alternative cleavage and polyadenylation: extent, regulation and function, Nat. Rev, vol.14, pp.496-506, 2013.

N. M. Nunes, W. Li, B. Tian, and A. Furger, A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence, EMBO J, vol.29, pp.1523-1536, 2010.

N. J. Proudfoot, Ending the message: poly(A) signals then and now, Genes Dev, vol.25, pp.1770-1782, 2011.

B. Tian, J. Hu, H. Zhang, and C. S. Lutz, A large-scale analysis of mRNA polyadenylation of human and mouse genes, Nucleic Acids Res, vol.33, pp.201-212, 2005.

E. Beaudoing, S. Freier, J. R. Wyatt, J. M. Claverie, and D. Gautheret, Patterns of variant polyadenylation signal usage in human genes, Genome Res, vol.10, pp.1001-1010, 2000.

A. R. Gruber, G. Martin, W. Keller, and M. Zavolan, Means to an end: mechanisms of alternative polyadenylation of messenger RNA precursors, Wiley Interdiscip. Rev, vol.5, pp.183-196, 2014.

S. Danckwardt, M. W. Hentze, and A. E. Kulozik, 3' end mRNA processing: molecular mechanisms and implications for health and disease, EMBO J, vol.27, pp.482-498, 2008.

A. Sachs, The role of poly(A) in the translation and stability of mRNA, Curr. Opin. Cell Biol, vol.2, pp.1092-1098, 1990.

I. Hollerer, K. Grund, M. W. Hentze, and A. E. Kulozik, mRNA 3'end processing: A tale of the tail reaches the clinic, EMBO Mol. Med, vol.6, pp.16-26, 2014.

R. Tawil, S. M. Van-der-maarel, and S. J. Tapscott, Facioscapulohumeral dystrophy: the path to consensus on pathophysiology, Skeletal Muscle, vol.4, p.12, 2014.

S. M. Van-der-maarel, D. G. Miller, R. Tawil, G. N. Filippova, and S. J. Tapscott, Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation, Curr. Opin. Neurol, vol.25, pp.614-620, 2012.

J. C. Van-deutekom, C. Wijmenga, E. A. Van-tienhoven, A. M. Gruter, J. E. Hewitt et al., FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit, Hum. Mol. Genet, vol.2, pp.2037-2042, 1993.

C. Wijmenga, J. E. Hewitt, L. A. Sandkuijl, L. N. Clark, T. J. Wright et al., Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy, Nat. Genet, vol.2, pp.26-30, 1992.

R. J. Lemmers, R. Tawil, L. M. Petek, J. Balog, G. J. Block et al., Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2, Nat. Genet, vol.44, pp.1370-1374, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00770764

R. J. Lemmers, M. L. Van-den-boogaard, . Van-der, P. J. Vliet, C. M. Donlin-smith et al., Hemizygosity for SMCHD1 in facioscapulohumeral muscular dystrophy Type 2: consequences for 18p deletion syndrome, Hum. Mutat, vol.36, pp.679-683, 2015.

R. J. Lemmers, . Van-der, P. J. Vliet, R. Klooster, S. Sacconi et al., A unifying genetic model for facioscapulohumeral muscular dystrophy, Science, vol.329, pp.1650-1653, 2010.

L. Snider, A. Asawachaicharn, A. E. Tyler, L. N. Geng, L. M. Petek et al., RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy, Hum. Mol. Genet, vol.18, pp.2414-2430, 2009.

L. Snider, L. N. Geng, R. J. Lemmers, M. Kyba, C. B. Ware et al., Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene, PLoS Genet, vol.6, p.1001181, 2010.

T. I. Jones, J. C. Chen, F. Rahimov, S. Homma, P. Arashiro et al., Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis, Hum. Mol. Genet, vol.21, pp.4419-4430, 2012.

N. Broucqsault, J. Morere, M. C. Gaillard, J. Dumonceaux, J. Torrents et al., Dysregulation of 4q35-and muscle-specific genes in fetuses with a short D4Z4 array linked to Facio-Scapulo-Humeral Dystrophy, Hum. Mol. Genet, vol.22, pp.4206-4214, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01662672

M. Ferreboeuf, V. Mariot, B. Bessieres, A. Vasiljevic, T. Attie-bitach et al., DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles, Hum. Mol. Genet, vol.23, pp.171-181, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01907613

G. J. Block, D. Narayanan, A. M. Amell, L. M. Petek, K. C. Davidson et al., , 2013.

, Wnt/beta-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells, Hum. Mol. Genet, vol.22, pp.390-396

M. Ferreboeuf, V. Mariot, D. Furling, G. Butler-browne, V. Mouly et al., Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases, Hum. Mol. Genet, vol.23, pp.4125-4133, 2014.

V. Kowaljow, A. Marcowycz, E. Ansseau, C. B. Conde, S. Sauvage et al., The DUX4 gene at the FSHD1A locus encodes a proapoptotic protein, Neuromuscul. Disord, vol.17, pp.611-623, 2007.

M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi et al., DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1, Proc. Natl Acad. Sci. USA, vol.104, pp.18157-18162, 2007.

L. M. Wallace, S. E. Garwick, W. Mei, A. Belayew, F. Coppee et al., DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo, Ann. Neurol, vol.69, pp.540-552, 2011.

L. N. Geng, Z. Yao, L. Snider, A. P. Fong, J. N. Cech et al., DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy, Dev. Cell, vol.22, pp.38-51, 2012.

H. Xu, Z. Wang, S. Jin, H. Hao, L. Zheng et al., Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression, Biochem. Biophys. Res. Commun, vol.446, pp.235-240, 2014.

A. M. Rickard, L. M. Petek, and D. G. Miller, Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways, Hum. Mol. Genet, vol.24, pp.5901-5914, 2015.

Q. Feng, L. Snider, S. Jagannathan, R. Tawil, S. M. Van-der-maarel et al., A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy, p.4, 2015.

R. Tupler, A. Berardinelli, L. Barbierato, R. Frants, J. E. Hewitt et al., Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy, J. Med. Genet, vol.33, pp.366-370, 1996.

R. J. Lemmers, P. De-kievit, L. Sandkuijl, G. W. Padberg, G. J. Van-ommen et al., Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere, Nat. Genet, vol.32, pp.235-236, 2002.

N. S. Thomas, K. Wiseman, G. Spurlock, M. Macdonald, D. Ustek et al., A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere, J. Med. Genet, vol.44, pp.215-218, 2007.

Z. Yao, L. Snider, J. Balog, R. J. Lemmers, S. M. Van-der-maarel et al., DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle, Hum. Mol. Genet, vol.23, pp.5342-5352, 2014.

L. M. Wallace, J. Liu, J. S. Domire, S. E. Garwick-coppens, S. M. Guckes et al., RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD Therapy, Mol. Ther, vol.20, pp.1417-1423, 2012.

H. Mitsuhashi, S. Mitsuhashi, T. Lynn-jones, G. Kawahara, and L. M. Kunkel, Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy, Hum. Mol. Genet, vol.22, pp.568-577, 2013.

C. Vanderplanck, E. Ansseau, S. Charron, N. Stricwant, A. Tassin et al., The FSHD atrophic myotube phenotype is caused by DUX4 expression, PLoS One, vol.6, p.26820, 2011.

R. Kole, A. R. Krainer, and S. Altman, RNA therapeutics: beyond RNA interference and antisense oligonucleotides, Nat. Rev. Drug Discov, vol.11, pp.125-140, 2012.

S. L. Devos and T. M. Miller, Antisense oligonucleotides: treating neurodegeneration at the level of RNA, Neurotherapeutics, vol.10, pp.486-497, 2013.

S. Cirak, V. Arechavala-gomeza, M. Guglieri, L. Feng, S. Torelli et al., Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an openlabel, phase 2, dose-escalation study, Lancet, vol.378, pp.595-605, 2011.

J. R. Mendell, L. R. Rodino-klapac, Z. Sahenk, K. Roush, L. Bird et al., Eteplirsen for the treatment of Duchenne muscular dystrophy, Ann. Neurol, vol.74, pp.637-647, 2013.

S. Jarmin, H. Kymalainen, L. Popplewell, and G. Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opin. Biol. Ther, vol.14, pp.209-230, 2013.

T. Voit, H. Topaloglu, V. Straub, F. Muntoni, N. Deconinck et al., Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study, Lancet, vol.13, pp.987-996, 2014.

V. Raz, H. Buijze, Y. Raz, N. Verwey, S. Y. Anvar et al., A novel feed-forward loop between ARIH2 E3-ligase and PABPN1 regulates agingassociated muscle degeneration, Am. J. Pathol, vol.184, pp.1119-1131, 2014.

T. A. Vickers, J. R. Wyatt, T. Burckin, C. F. Bennett, and S. M. Freier, Fully modified 2' MOE oligonucleotides redirect polyadenylation, Nucleic Acids Res, vol.29, pp.1293-1299, 2001.
DOI : 10.1093/nar/29.6.1293
URL : https://academic.oup.com/nar/article-pdf/29/6/1293/9900905/291293.pdf

V. Mariot, S. Roche, C. Hourde, D. Portilho, S. Sacconi et al., Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy, Ann. Neurol, vol.78, pp.387-400, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01431338

S. Millevoi and S. Vagner, Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation, Nucleic Acids Res, vol.38, pp.2757-2774, 2010.

M. Zuker, Mfold web server for nucleic acid folding and hybridization prediction, Nucleic Acids Res, vol.31, pp.3406-3415, 2003.
DOI : 10.1093/nar/gkg595
URL : https://academic.oup.com/nar/article-pdf/31/13/3406/9487491/gkg595.pdf

J. C. Wu, D. P. Gardner, S. Ozer, R. R. Gutell, and P. Ren, Correlation of RNA secondary structure statistics with thermodynamic stability and applications to folding, J. Mol. Biol, vol.391, pp.769-783, 2009.

T. Wada, M. Hara, T. Taneda, C. Qingfu, R. Takata et al., Antisense morpholino targeting just upstream from a poly(A) tail junction of maternal mRNA removes the tail and inhibits translation, Nucleic Acids Res, vol.40, p.173, 2012.

A. B. Eberle, L. Stalder, H. Mathys, R. Z. Orozco, and O. Muhlemann, Posttranscriptional gene regulation by spatial rearrangement of the 3' untranslated region, PLoS Biol, vol.6, p.92, 2008.

M. Jenal, R. Elkon, F. Loayza-puch, G. Van-haaften, U. Kuhn et al., The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, vol.149, pp.538-553, 2012.

S. Uitte-de-willige, I. M. Rietveld, M. C. Visser, H. L. Vos, and R. M. Bertina, Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio, J. Thromb. Haemost, vol.5, pp.1243-1249, 2007.

A. Wiestner, M. Tehrani, M. Chiorazzi, G. Wright, F. Gibellini et al., Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival, Blood, vol.109, pp.4599-4606, 2007.
DOI : 10.1182/blood-2006-08-039859
URL : http://www.bloodjournal.org/content/bloodjournal/109/11/4599.full.pdf

L. J. Popplewell, I. R. Graham, A. Malerba, and G. Dickson, Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle, Methods Mol. Biol, vol.709, pp.153-178, 2011.

Y. D. Krom, J. Dumonceaux, K. Mamchaoui, B. Hamer, V. Mariot et al., Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD, Am. J. Pathol, vol.181, pp.1387-1401, 2012.

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin. Chem, vol.55, pp.611-622, 2009.

S. A. Afione, C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams et al., In vivo model of adeno-associated virus vector persistence and rescue, J. Virol, vol.70, pp.3235-3241, 1996.

A. Agrotis and R. Ketteler, A new age in functional genomics using CRISPR/Cas9 in arrayed library screening, Front. Genet, vol.6, 2015.

B. Akache, D. Grimm, K. Pandey, S. R. Yant, H. Xu et al., The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9, J. Virol, vol.80, pp.9831-9836, 2006.

B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts et al., Chromosomal DNA and Its Packaging in the Chromatin Fiber, 2002.

M. J. Allikian, G. Bhabha, P. Dospoy, A. Heydemann, P. Ryder et al., Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants, Hum. Mol. Genet, vol.16, pp.2933-2943, 2007.

D. Ames, N. Murphy, T. Helentjaris, N. Sun, C. et al., Comparative analyses of human single-and multilocus tandem repeats, Genetics, vol.179, pp.1693-1704, 2008.

G. Amitai and R. Sorek, CRISPR-Cas adaptation: insights into the mechanism of action, Nat. Rev. Microbiol, vol.14, pp.67-76, 2016.

G. Andersen, K. P. Prahm, J. R. Dahlqvist, G. Citirak, and J. Vissing, Aerobic training and postexercise protein in facioscapulohumeral muscular dystrophy: RCT study, Neurology, vol.85, pp.396-403, 2015.

F. M. André, J. Gehl, G. Sersa, V. Préat, P. Hojman et al., Efficiency of high-and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin, Hum. Gene Ther, vol.19, pp.1261-1271, 2008.

C. Andreassi and A. Riccio, To localize or not to localize: mRNA fate is in 3'UTR ends, Trends Cell Biol, vol.19, pp.465-474, 2009.

E. D. Andrulis, A. M. Neiman, D. C. Zappulla, and R. Sternglanz, Perinuclear localization of chromatin facilitates transcriptional silencing, Nature, vol.394, pp.592-595, 1998.

E. Ansseau, D. Laoudj-chenivesse, A. Marcowycz, A. Tassin, C. Vanderplanck et al., DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation, PloS One, vol.4, p.7482, 2009.

E. Ansseau, J. O. Eidahl, C. Lancelot, A. Tassin, C. Matteotti et al., Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation, PLOS ONE, vol.11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01802787

T. J. Antes, S. J. Namciu, R. E. Fournier, and B. Levy-wilson, The 5' boundary of the human apolipoprotein B chromatin domain in intestinal cells, Biochemistry (Mosc.), vol.40, pp.6731-6742, 2001.

K. Arahata, T. Ishihara, H. Fukunaga, S. Orimo, J. H. Lee et al., Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses, Muscle Nerve. Suppl, vol.2, pp.56-66, 1995.

. Aran, Recherches sur une maladie non encore décrit du système musculaire (atrophie musculaire progressive), Arch. Générales Médecine, vol.3, p.172, 1850.

P. Arashiro, I. Eisenberg, A. T. Kho, A. M. Cerqueira, M. Canovas et al., Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.6220-6225, 2009.

O. Argyros, S. P. Wong, M. Niceta, S. N. Waddington, S. J. Howe et al., Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector, Gene Ther, vol.15, pp.1593-1605, 2008.

S. Arnould, P. Chames, C. Perez, E. Lacroix, A. Duclert et al., Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets, J. Mol. Biol, vol.355, pp.443-458, 2006.

J. Ashworth, J. J. Havranek, C. M. Duarte, D. Sussman, R. J. Monnat et al., Computational redesign of endonuclease DNA binding and cleavage specificity, Nature, vol.441, pp.656-659, 2006.

S. Attarian, E. Salort-campana, K. Nguyen, A. Behin, A. Urtizberea et al., Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011, Rev. Neurol, vol.168, pp.910-918, 2012.

G. I. Awerbuch, M. A. Nigro, and R. Wishnow, Beevor's sign and facioscapulohumeral dystrophy, Arch. Neurol, vol.47, pp.1208-1209, 1990.

E. Ayuso, F. Mingozzi, and F. Bosch, Production, purification and characterization of adenoassociated vectors, Curr. Gene Ther, vol.10, pp.423-436, 2010.

E. Bakker, C. Wijmenga, R. H. Vossen, G. W. Padberg, J. Hewitt et al., The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter, Muscle Nerve. Suppl, vol.2, pp.39-44, 1995.

B. J. Baldwin, R. C. Talley, C. Johnson, and D. O. Nutter, Permanent paralysis of the atrium in a patient with facioscapulohumeral muscular dystrophy, Am. J. Cardiol, vol.31, pp.649-653, 1973.

L. Bankolé, G. Y. Millet, J. Temesi, D. Bachasson, M. Ravelojaona et al., Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial, p.4497, 2016.

A. J. Bannister, P. Zegerman, J. F. Partridge, E. A. Miska, J. O. Thomas et al., Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain, Nature, vol.410, pp.120-124, 2001.

S. M. Barabino and W. Keller, Last but not least: regulated poly(A) tail formation, Cell, vol.99, pp.9-11, 1999.

A. Bareja, J. A. Holt, G. Luo, C. Chang, J. Lin et al., Human and mouse skeletal muscle stem cells: convergent and divergent mechanisms of myogenesis, PloS One, vol.9, p.90398, 2014.

R. Barrangou, C. Fremaux, H. Deveau, M. Richards, P. Boyaval et al., CRISPR provides acquired resistance against viruses in prokaryotes, Science, vol.315, pp.1709-1712, 2007.

M. Barro, G. Carnac, S. Flavier, J. Mercier, Y. Vassetzky et al., , 2010.

, Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects, J. Cell. Mol. Med, vol.14, pp.275-289

J. S. Bartlett, R. Wilcher, and R. J. Samulski, Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors, J. Virol, vol.74, pp.2777-2785, 2000.

A. R. Bassett, C. Tibbit, C. P. Ponting, and J. Liu, Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system, Cell Rep, vol.4, pp.220-228, 2013.

C. Baum, O. Kustikova, U. Modlich, Z. Li, and B. Fehse, Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors, Hum. Gene Ther, vol.17, pp.253-263, 2006.

J. A. Baur, Y. Zou, J. W. Shay, and W. E. Wright, Telomere position effect in human cells, Science, vol.292, pp.2075-2077, 2001.

J. Baxter, M. Merkenschlager, and A. G. Fisher, Nuclear organisation and gene expression, Curr. Opin. Cell Biol, vol.14, pp.372-376, 2002.

E. Beaudoing, S. Freier, J. R. Wyatt, J. M. Claverie, and D. Gautheret, Patterns of variant polyadenylation signal usage in human genes, Genome Res, vol.10, pp.1001-1010, 2000.

J. S. Beckmann and M. Spencer, Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance, Neuromuscul. Disord. NMD, vol.18, pp.913-921, 2008.

V. M. Bedell, Y. Wang, J. M. Campbell, T. L. Poshusta, C. G. Starker et al., In vivo genome editing using a highefficiency TALEN system, Nature, vol.491, pp.114-118, 2012.

R. R. Beerli, D. J. Segal, B. Dreier, and C. F. Barbas, Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.14628-14633, 1998.

R. R. Beerli, B. Dreier, and C. F. Barbas, Positive and negative regulation of endogenous genes by designed transcription factors, Proc. Natl. Acad. Sci. U. S. A, vol.97, pp.1495-1500, 2000.

A. C. Bell and G. Felsenfeld, Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene, Nature, vol.405, pp.482-485, 2000.

N. E. Bengtsson, J. K. Hall, G. L. Odom, M. P. Phelps, C. R. Andrus et al., Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy, Nat. Commun, vol.8, p.14454, 2017.
DOI : 10.1038/ncomms14454
URL : https://www.nature.com/articles/ncomms14454.pdf

U. Bengtsson, M. R. Altherr, J. J. Wasmuth, and S. T. Winokur, High resolution fluorescence in situ hybridization to linearly extended DNA visually maps a tandem repeat associated with facioscapulohumeral muscular dystrophy immediately adjacent to the telomere of 4q, Hum. Mol. Genet, vol.3, pp.1801-1805, 1994.

F. C. Bennett and K. F. Harvey, Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway, Curr. Biol. CB, vol.16, pp.2101-2110, 2006.
DOI : 10.1016/j.cub.2006.09.045
URL : https://doi.org/10.1016/j.cub.2006.09.045

C. L. Bennett, M. E. Brunkow, F. Ramsdell, K. C. O'briant, Q. Zhu et al., A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome, Immunogenetics, vol.53, pp.435-439, 2001.

A. Bensimon, A. Simon, A. Chiffaudel, V. Croquette, F. Heslot et al., , 1994.

, Alignment and sensitive detection of DNA by a moving interface, Science, vol.265, pp.2096-2098

C. F. Bentzinger, Y. X. Wang, and M. A. Rudnicki, Building Muscle: Molecular Regulation of Myogenesis, Cold Spring Harb. Perspect. Biol, vol.4, p.8342, 2012.
DOI : 10.1101/cshperspect.a008342
URL : http://cshperspectives.cshlp.org/content/4/2/a008342.full.pdf

Y. Bergman and H. Cedar, DNA methylation dynamics in health and disease, Nat. Struct. Mol. Biol, vol.20, pp.274-281, 2013.

P. Bernard, J. F. Maure, J. F. Partridge, S. Genier, J. P. Javerzat et al., Requirement of heterochromatin for cohesion at centromeres, Science, vol.294, pp.2539-2542, 2001.
DOI : 10.1126/science.1064027

B. E. Bernstein, M. Kamal, K. Lindblad-toh, S. Bekiranov, D. K. Bailey et al., Genomic maps and comparative analysis of histone modifications in human and mouse, Cell, vol.120, pp.169-181, 2005.

E. Bernstein, A. A. Caudy, S. M. Hammond, and G. J. Hannon, Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature, vol.409, pp.363-366, 2001.

E. Berto, A. Bozac, and P. Marconi, Development and application of replication-incompetent HSV-1-based vectors, Gene Ther, vol.12, issue.1, pp.98-102, 2005.

N. Bessis, F. J. Garciacozar, and M. Boissier, Immune responses to gene therapy vectors: influence on vector function and effector mechanisms, Gene Ther, vol.11, issue.1, pp.10-17, 2004.
DOI : 10.1038/sj.gt.3302364
URL : https://www.nature.com/articles/3302364.pdf

S. Bessonov, M. Anokhina, A. Krasauskas, M. M. Golas, B. Sander et al., Characterization of purified human Bact spliceosomal complexes reveals compositional and morphological changes during spliceosome activation and first step catalysis, vol.16, pp.2384-2403, 2010.
DOI : 10.1261/rna.2456210
URL : http://rnajournal.cshlp.org/content/16/12/2384.full.pdf

T. H. Bestor, The DNA methyltransferases of mammals, Hum. Mol. Genet, vol.9, pp.2395-2402, 2000.

C. Betts, A. F. Saleh, A. A. Arzumanov, S. M. Hammond, C. Godfrey et al., Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment, Mol. Ther. Nucleic Acids, vol.1, p.38, 2012.

M. Bibikova, D. Carroll, D. J. Segal, J. K. Trautman, J. Smith et al., Stimulation of homologous recombination through targeted cleavage by chimeric nucleases, Mol. Cell. Biol, vol.21, pp.289-297, 2001.
DOI : 10.1128/mcb.21.1.289-297.2001
URL : https://mcb.asm.org/content/21/1/289.full.pdf

W. A. Bickmore, V. D. Maarel, M. , and S. , Perturbations of chromatin structure in human genetic disease: recent advances, Hum. Mol. Genet, vol.12, pp.207-213, 2003.

L. T. Bish, M. M. Sleeper, S. C. Forbes, K. J. Morine, C. Reynolds et al., Long-term systemic myostatin inhibition via livertargeted gene transfer in golden retriever muscular dystrophy, Hum. Gene Ther, vol.22, pp.1499-1509, 2011.
DOI : 10.1089/hum.2011.102
URL : http://europepmc.org/articles/pmc3237695?pdf=render

R. M. Blaese, K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher et al., T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years, Science, vol.270, pp.475-480, 1995.

M. E. Blewitt, A. Gendrel, Z. Pang, D. B. Sparrow, N. Whitelaw et al., SmcHD1, containing a structuralmaintenance-of-chromosomes hinge domain, has a critical role in X inactivation, Nat. Genet, vol.40, pp.663-669, 2008.

G. J. Block, L. M. Petek, D. Narayanan, A. M. Amell, J. M. Moore et al., Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production, PloS One, vol.7, p.35532, 2012.

G. J. Block, D. Narayanan, A. M. Amell, L. M. Petek, K. C. Davidson et al., Wnt/?-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells, Hum. Mol. Genet, vol.22, pp.4661-4672, 2013.

J. Boch, H. Scholze, S. Schornack, A. Landgraf, S. Hahn et al., Breaking the code of DNA binding specificity of TAL-type III effectors, Science, vol.326, pp.1509-1512, 2009.

O. Bockstael, K. D. Foust, B. Kaspar, and L. Tenenbaum, Recombinant AAV delivery to the central nervous system, Methods Mol. Biol. Clifton NJ, vol.807, pp.159-177, 2011.

J. Bode, C. Benham, A. Knopp, and C. Mielke, Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements), Crit. Rev. Eukaryot. Gene Expr, vol.10, pp.73-90, 2000.

B. Bodega, G. D. Ramirez, F. Grasser, S. Cheli, S. Brunelli et al., Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation, BMC Biol, vol.7, p.41, 2009.

S. C. Bodine and L. M. Baehr, Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1, Am. J. Physiol. Endocrinol. Metab, vol.307, pp.469-484, 2014.

S. C. Bodine, E. Latres, S. Baumhueter, V. K. Lai, L. Nunez et al., Identification of ubiquitin ligases required for skeletal muscle atrophy, Science, vol.294, pp.1704-1708, 2001.

A. J. Bogdanove and D. F. Voytas, TAL effectors: customizable proteins for DNA targeting, Science, vol.333, pp.1843-1846, 2011.

M. Bonner and E. B. Kmiec, DNA breakage associated with targeted gene alteration directed by DNA oligonucleotides, Mutat. Res, vol.669, pp.85-94, 2009.

M. L. Van-den-boogaard, R. Lemmers, P. Camaño, . Van-der, P. J. Vliet et al., Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2, Eur. J. Hum. Genet. EJHG. van den Boogaard, vol.98, pp.1020-1029, 2015.

H. A. Booth and P. W. Holland, Annotation, nomenclature and evolution of four novel homeobox genes expressed in the human germ line, Gene, vol.387, pp.7-14, 2007.

C. Bordignon, L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati et al., Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients, Science, vol.270, pp.470-475, 1995.

S. Bortolanza, A. Nonis, F. Sanvito, S. Maciotta, G. Sitia et al., AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy, Mol. Ther. J. Am. Soc. Gene Ther, vol.19, pp.2055-2064, 2011.

D. Bosnakovski, Z. Xu, E. J. Gang, C. L. Galindo, M. Liu et al., An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies, EMBO J, vol.27, pp.2766-2779, 2008.

D. Bosnakovski, S. H. Choi, J. M. Strasser, E. A. Toso, M. A. Walters et al., Highthroughput screening identifies inhibitors of DUX4-induced myoblast toxicity, 2014.

D. Bouard, N. Alazard-dany, and F. Cosset, Viral vectors: from virology to transgene expression, Br. J. Pharmacol, vol.157, pp.153-165, 2009.

M. D. Brand, J. L. Pakay, A. Ocloo, J. Kokoszka, D. C. Wallace et al., The basal proton conductance of mitochondria depends on adenine nucleotide translocase content, Biochem. J, vol.392, pp.353-362, 2005.

T. Braun and M. Gautel, Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis, Nat. Rev. Mol. Cell Biol, vol.12, pp.349-361, 2011.

N. J. Brideau, H. Coker, A. Gendrel, C. A. Siebert, K. Bezstarosti et al., Independent Mechanisms Target SMCHD1 to Trimethylated Histone H3 Lysine 9-Modified Chromatin and the Inactive X Chromosome, Mol. Cell. Biol, vol.35, pp.4053-4068, 2015.

D. G. Brockstedt, G. M. Podsakoff, L. Fong, G. Kurtzman, W. Mueller-ruchholtz et al., Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration, Clin. Immunol. Orlando Fla, vol.92, pp.67-75, 1999.

N. Broucqsault, J. Morere, M. Gaillard, J. Dumonceaux, J. Torrents et al., Dysregulation of 4q35-and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy, Hum. Mol. Genet, vol.22, pp.4206-4214, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01662672

J. R. Brouwer, R. Willemsen, and B. A. Oostra, Microsatellite repeat instability and neurological disease, BioEssays News Rev. Mol. Cell. Dev. Biol, vol.31, pp.71-83, 2009.

O. F. Brouwer, G. W. Padberg, C. J. Ruys, R. Brand, J. A. De-laat et al., Hearing loss in facioscapulohumeral muscular dystrophy, Neurology, vol.41, pp.1878-1881, 1991.

J. V. Brower, N. Rodic, T. Seki, M. Jorgensen, N. Fliess et al., Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis, J. Biol. Chem, vol.282, pp.29658-29666, 2007.

S. J. Brown, P. Stoilov, and Y. Xing, Chromatin and epigenetic regulation of pre-mRNA processing, Hum. Mol. Genet, vol.21, pp.90-96, 2012.

C. Brun, D. Suter, C. Pauli, P. Dunant, H. Lochmüller et al., U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping, Cell. Mol. Life Sci. CMLS, vol.60, pp.557-566, 2003.

M. Buckingham, Myogenic progenitor cells and skeletal myogenesis in vertebrates, Curr. Opin. Genet. Dev, vol.16, pp.525-532, 2006.

A. Buj-bello, D. Furling, H. Tronchère, J. Laporte, T. Lerouge et al., Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells, Hum. Mol. Genet, vol.11, pp.2297-2307, 2002.

H. R. Büller, D. Gailani, and J. I. Weitz, Factor XI antisense oligonucleotide for venous thrombosis, N. Engl. J. Med, vol.372, p.1672, 2015.

R. M. Buller, J. E. Janik, E. D. Sebring, and J. A. Rose, Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication, J. Virol, vol.40, pp.241-247, 1981.

H. Büning, L. Perabo, O. Coutelle, S. Quadt-humme, and M. Hallek, Recent developments in adeno-associated virus vector technology, J. Gene Med, vol.10, pp.717-733, 2008.

M. Buongiorno-nardelli, G. Micheli, M. T. Carri, and M. Marilley, A relationship between replicon size and supercoiled loop domains in the eukaryotic genome, Nature, vol.298, pp.100-102, 1982.

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin. Chem, vol.55, pp.611-622, 2009.

D. S. Cabianca, V. Casa, B. Bodega, A. Xynos, E. Ginelli et al., A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy, Cell, vol.149, pp.819-831, 2012.

S. Cacurri, N. Piazzo, G. Deidda, E. Vigneti, G. Galluzzi et al., Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet, vol.63, pp.181-190, 1998.

I. Cantone and A. G. Fisher, Epigenetic programming and reprogramming during development, Nat. Struct. Mol. Biol, vol.20, pp.282-289, 2013.

S. Canudas, B. R. Houghtaling, M. Bhanot, G. Sasa, S. A. Savage et al., A role for heterochromatin protein 1? at human telomeres, Genes Dev, vol.25, pp.1807-1819, 2011.

D. Carroll, Zinc-finger Nucleases as Gene Therapy Agents, Gene Ther, vol.15, pp.1463-1468, 2008.
DOI : 10.1038/gt.2008.145
URL : https://www.nature.com/articles/gt2008145.pdf

N. Caruso, B. Herberth, M. Bartoli, F. Puppo, J. Dumonceaux et al., Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy, PLoS Genet, vol.9, p.1003550, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00862092

T. Cathomen and J. K. Joung, Zinc-finger nucleases: the next generation emerges, Mol. Ther. J. Am. Soc. Gene Ther, vol.16, pp.1200-1207, 2008.

M. Cavazzana-calvo, S. Hacein-bey, . De-saint, G. Basile, F. Gross et al., Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Science, vol.288, pp.669-672, 2000.

H. Cedar and Y. Bergman, Programming of DNA methylation patterns, Annu. Rev. Biochem, vol.81, pp.97-117, 2012.

B. Celegato, D. Capitanio, M. Pescatori, C. Romualdi, B. Pacchioni et al., Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes, Proteomics, vol.6, pp.5303-5321, 2006.

S. M. Cerritelli and R. J. Crouch, Ribonuclease H: the enzymes in eukaryotes, FEBS J, vol.276, pp.1494-1505, 2009.

Y. B. Chan, I. Miguel-aliaga, C. Franks, N. Thomas, B. Trülzsch et al., Neuromuscular defects in a Drosophila survival motor neuron gene mutant, Hum. Mol. Genet, vol.12, pp.1367-1376, 2003.

N. Chang, C. Sun, L. Gao, D. Zhu, X. Xu et al., Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos, Cell Res, vol.23, pp.465-472, 2013.

Y. Chang, J. S. Imam, and M. F. Wilkinson, The nonsense-mediated decay RNA surveillance pathway, Annu. Rev. Biochem, vol.76, pp.51-74, 2007.

A. Chartier, B. Benoit, and M. Simonelig, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, EMBO J, vol.25, pp.2253-2262, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00069833

T. Chaudhuri, M. Mukherjea, S. Sachdev, J. D. Randall, and S. Sarkar, Role of the fetal and alpha/beta exons in the function of fast skeletal troponin T isoforms: correlation with altered Ca2+ regulation associated with development, J. Mol. Biol, vol.352, pp.58-71, 2005.

S. Cheli, S. François, B. Bodega, F. Ferrari, E. Tenedini et al., Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns, PloS One, vol.6, 2011.

J. C. Chen, O. D. King, Y. Zhang, N. P. Clayton, C. Spencer et al., Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics, Mol. Ther, vol.24, pp.1405-1411, 2016.

K. Chen, P. E. Czabotar, M. E. Blewitt, and J. M. Murphy, The hinge domain of the epigenetic repressor Smchd1 adopts an unconventional homodimeric configuration, Biochem. J, vol.473, pp.733-742, 2016.

S. C. Chen, E. Frett, J. Marx, D. Bosnakovski, X. Reed et al., Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1, PloS One, vol.6, 2011.
DOI : 10.1371/journal.pone.0019780
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0019780&type=printable

T. Chen, Y. Ueda, J. E. Dodge, Z. Wang, L. et al., Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b, Mol. Cell. Biol, vol.23, pp.5594-5605, 2003.

T. Chen, N. Tsujimoto, L. , and E. , The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin, Mol. Cell. Biol, vol.24, pp.9048-9058, 2004.

X. Cheng and R. M. Blumenthal, Mammalian DNA methyltransferases: a structural perspective, Struct. Lond. Engl, vol.16, pp.341-350, 1993.
DOI : 10.1016/j.str.2008.01.004
URL : https://doi.org/10.1016/j.str.2008.01.004

B. S. Chevalier and B. L. Stoddard, Homing endonucleases: structural and functional insight into the catalysts of intron/intein mobility, Nucleic Acids Res, vol.29, pp.3757-3774, 2001.

N. Chirmule, K. Propert, S. Magosin, Y. Qian, R. Qian et al., Immune responses to adenovirus and adeno-associated virus in humans, Gene Ther, vol.6, pp.1574-1583, 1999.

E. Cho, Y. Feng, C. Rauskolb, S. Maitra, R. Fehon et al., Delineation of a Fat tumor suppressor pathway, Nat. Genet, vol.38, pp.1142-1150, 2006.

M. Christian, T. Cermak, E. L. Doyle, C. Schmidt, F. Zhang et al., Targeting DNA double-strand breaks with TAL effector nucleases, Genetics, vol.186, pp.757-761, 2010.

L. Ciani, A. Patel, N. D. Allen, and C. Constant, Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype, Mol. Cell. Biol, vol.23, pp.3575-3582, 2003.

R. Ciosk, M. Shirayama, A. Shevchenko, T. Tanaka, A. Toth et al.,

, Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins, Mol. Cell, vol.5, pp.243-254

J. Clapp, L. M. Mitchell, D. J. Bolland, J. Fantes, A. E. Corcoran et al., Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet, vol.81, pp.264-279, 2007.

M. Cockell and S. M. Gasser, Nuclear compartments and gene regulation, Curr. Opin. Genet. Dev, vol.9, pp.199-205, 1999.

P. N. Cockerill and W. T. Garrard, Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites, Cell, vol.44, pp.273-282, 1986.

H. Coker and N. Brockdorff, SMCHD1 accumulates at DNA damage sites and facilitates the repair of DNA double-strand breaks, J. Cell Sci, vol.127, pp.1869-1874, 2014.

N. J. Cole, M. Tanaka, A. Prescott, and C. Tickle, Expression of limb initiation genes and clues to the morphological diversification of threespine stickleback, Curr. Biol. CB, vol.13, pp.951-952, 2003.

C. A. Collins and T. A. Partridge, Self-renewal of the adult skeletal muscle satellite cell, Cell Cycle Georget. Tex, vol.4, pp.1338-1341, 2005.

K. Collins and J. R. Mitchell, Telomerase in the human organism, Oncogene, vol.21, pp.564-579, 2002.

S. S. Colson, M. Benchortane, V. Tanant, J. Faghan, M. Fournier-mehouas et al., Neuromuscular electrical stimulation training: a safe and effective treatment for facioscapulohumeral muscular dystrophy patients, Arch. Phys. Med. Rehabil, vol.91, pp.697-702, 2010.

T. I. Cornu and T. Cathomen, Quantification of zinc finger nuclease-associated toxicity, Methods Mol. Biol. Clifton NJ, vol.649, pp.237-245, 2010.

B. Cox, A. K. Hadjantonakis, J. E. Collins, and A. I. Magee, Cloning and expression throughout mouse development of mfat1, a homologue of the Drosophila tumour suppressor gene fat, Dev. Dyn. Off. Publ. Am. Assoc. Anat, vol.217, pp.233-240, 2000.

D. B. Cox, R. J. Platt, and F. Zhang, Therapeutic Genome Editing: Prospects and Challenges, Nat. Med, vol.21, pp.121-131, 2015.

T. Cremer and C. Cremer, Chromosome territories, nuclear architecture and gene regulation in mammalian cells, Nat. Rev. Genet, vol.2, pp.292-301, 2001.

. Cruveilhier, Sur la paralysie musculaire, progressive, atrophique. Bull. L'académie Natl, Médecine 17ième Année, vol.490, 1852.

R. G. Crystal, In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors, Cancer Chemother. Pharmacol, vol.43, pp.90-99, 1999.

A. K. Csink and S. Henikoff, Genetic modification of heterochromatic association and nuclear organization in Drosophila, Nature, vol.381, pp.529-531, 1996.

B. R. Cullen, Induction of stable RNA interference in mammalian cells, Gene Ther, vol.13, pp.503-508, 2005.

E. H. Cup, A. J. Pieterse, J. M. Ten-broek-pastoor, M. Munneke, B. G. Van-engelen et al., Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review, Arch. Phys. Med. Rehabil, vol.88, pp.1452-1464, 2007.

T. Czerny and M. Busslinger, DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5), Mol. Cell. Biol, vol.15, pp.2858-2871, 1995.

J. E. Dahlberg and E. Lund, Structure and expression of U-snRNA genes, Mol. Biol. Rep, vol.12, pp.139-143, 1987.

A. Damianov and D. L. Black, Autoregulation of Fox protein expression to produce dominant negative splicing factors, vol.16, pp.405-416, 2010.

S. Danckwardt, M. W. Hentze, and A. E. Kulozik, 3? end mRNA processing: molecular mechanisms and implications for health and disease, EMBO J, vol.27, pp.482-498, 2008.

A. Dandapat, D. Bosnakovski, L. M. Hartweck, R. W. Arpke, K. A. Baltgalvis et al., Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4, Transgene. Cell Rep, vol.8, pp.1484-1496, 2014.

S. Das and B. P. Chadwick, Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells, PLoS ONE, vol.11, 2016.

C. G. Davis, The many faces of epidermal growth factor repeats, New Biol, vol.2, pp.410-419, 1990.

S. Daya and K. I. Berns, Gene Therapy Using Adeno-Associated Virus Vectors, Clin. Microbiol. Rev, vol.21, pp.583-593, 2008.

F. G. De-angelis, O. Sthandier, B. Berarducci, S. Toso, G. Galluzzi et al., Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells, Proc. Natl. Acad. Sci. U. S. A, vol.99, pp.9456-9461, 2002.

K. L. Deak, R. J. Lemmers, J. M. Stajich, R. Klooster, R. Tawil et al., Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4, Neurology, vol.68, pp.578-582, 2007.

D. A. Dean, Peptide nucleic acids: versatile tools for gene therapy strategies, Adv. Drug Deliv. Rev, vol.44, pp.81-95, 2000.

S. Decary, C. B. Hamida, V. Mouly, J. P. Barbet, F. Hentati et al., , 2000.

, Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children, Neuromuscul. Disord. NMD, vol.10, pp.113-120

G. Deidda, S. Cacurri, P. Grisanti, E. Vigneti, N. Piazzo et al., Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter, Eur. J. Hum. Genet. EJHG, vol.3, pp.155-167, 1995.

G. Deidda, S. Cacurri, N. Piazzo, and L. Felicetti, Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD), J. Med. Genet, vol.33, pp.361-365, 1996.

J. Déjardin and R. E. Kingston, Purification of proteins associated with specific genomic Loci, Cell, vol.136, pp.175-186, 2009.

D. and L. , De la myopathie atrophique progressive (myopathie héréditaire débutant, dans l'enfance, par la face, sans altération du système nerveux), Comptes Rendus Hebd. Séances L'académie Sci, vol.98, p.53, 1884.

A. Dellavalle, M. Sampaolesi, R. Tonlorenzi1, E. Tagliafico, B. Sacchetti et al., Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells, Nat. Cell Biol, vol.9, pp.255-267, 2007.

D. Deng, C. Yan, X. Pan, M. Mahfouz, J. Wang et al., Structural basis for sequence-specific recognition of DNA by TAL effectors, Science, vol.335, pp.720-723, 2012.

M. A. Denti, A. Rosa, G. D'antona, O. Sthandier, F. G. De-angelis et al., Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice, Hum. Gene Ther, vol.17, pp.565-574, 2006.

J. R. Desjarlais and J. M. Berg, Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins, Proc. Natl. Acad. Sci. U. S. A, vol.90, pp.2256-2260, 1993.

J. C. Van-deutekom, C. Wijmenga, E. A. Van-tienhoven, A. M. Gruter, J. E. Hewitt et al., FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit, Hum. Mol. Genet, vol.2, pp.2037-2042, 1993.

J. C. Van-deutekom, E. Bakker, R. J. Lemmers, M. J. Van-der-wielen, E. Bik et al., Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1, Hum. Mol. Genet, vol.5, 1996.

J. C. Van-deutekom, R. J. Lemmers, P. K. Grewal, M. Van-geel, S. Romberg et al., Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35, Hum. Mol. Genet, vol.5, pp.581-590, 1996.

J. Devincenzo, J. E. Cehelsky, R. Alvarez, S. Elbashir, J. Harborth et al., Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV), Antiviral Res, vol.77, pp.225-231, 2008.

S. L. Devos and T. M. Miller, Antisense oligonucleotides: treating neurodegeneration at the level of RNA, Neurother. J. Am. Soc. Exp. Neurother, vol.10, pp.486-497, 2013.

D. C. Di-giammartino, K. Nishida, and J. L. Manley, Mechanisms and consequences of alternative polyadenylation, Mol. Cell, vol.43, pp.853-866, 2011.

N. Dias and C. A. Stein, Antisense Oligonucleotides: Basic Concepts and Mechanisms, Mol. Cancer Ther, vol.1, pp.347-355, 2002.

N. Dillon, Heterochromatin structure and function, Biol. Cell, vol.96, pp.631-637, 2004.

M. A. Dimattia, H. Nam, K. Van-vliet, M. Mitchell, A. Bennett et al., Structural insight into the unique properties of adeno-associated virus serotype 9, J. Virol, vol.86, pp.6947-6958, 2012.

P. Dimitri, R. Caizzi, E. Giordano, M. Carmela-accardo, G. Lattanzi et al., , 2009.

, Constitutive heterochromatin: a surprising variety of expressed sequences, Chromosoma, vol.118, pp.419-435

H. Ding, M. C. Beckers, S. Plaisance, P. Marynen, D. Collen et al., Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements, Hum. Mol. Genet, vol.7, pp.1681-1694, 1998.

W. Ding, L. Zhang, Z. Yan, and J. F. Engelhardt, Intracellular trafficking of adeno-associated viral vectors, Gene Ther, vol.12, pp.873-880, 2005.

M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi et al., DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.18157-18162, 2007.

P. Dmitriev, A. Petrov, E. Ansseau, L. Stankevicins, S. Charron et al., The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy, J. Biol. Chem, vol.286, pp.44620-44631, 2011.

A. Doerner, M. Pauschinger, A. Badorff, M. Noutsias, S. Giessen et al., Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans, FEBS Lett, vol.414, pp.258-262, 1997.

V. Dolce, P. Scarcia, D. Iacopetta, and F. Palmieri, A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution, FEBS Lett, vol.579, pp.633-637, 2005.

Z. Dominski and W. F. Marzluff, Formation of the 3' end of histone mRNA, Gene, vol.239, pp.1-14, 1999.

Z. Dominski and W. F. Marzluff, Formation of the 3' end of histone mRNA: getting closer to the end, Gene, vol.396, pp.373-390, 2007.

Z. Dominski, L. X. Zheng, R. Sanchez, and W. F. Marzluff, Stem-loop binding protein facilitates 3'-end formation by stabilizing U7 snRNP binding to histone pre-mRNA, Mol. Cell. Biol, vol.19, pp.3561-3570, 1999.

Z. Dominski, J. A. Erkmann, X. Yang, R. Sànchez, and W. F. Marzluff, A novel zinc finger protein is associated with U7 snRNP and interacts with the stem-loop binding protein in the histone pre-mRNP to stimulate 3?-end processing, Genes Dev, vol.16, pp.58-71, 2002.

Z. Dominski, X. Yang, and W. F. Marzluff, The polyadenylation factor CPSF-73 is involved in histone-pre-mRNA processing, Cell, vol.123, pp.37-48, 2005.

M. Dorobek, E. Szmidt-sa?kowska, K. Rowi?ska-marci?ska, M. Gawe?, and I. Hausmanowapetrusewicz, Relationships between clinical data and quantitative EMG findings in facioscapulohumeral muscular dystrophy, Neurol. Neurochir. Pol, vol.47, pp.8-17, 2013.

A. Douar, K. Poulard, D. Stockholm, and O. Danos, Intracellular Trafficking of AdenoAssociated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degradation, J. Virol, vol.75, pp.1824-1833, 2001.

B. Dreier, R. R. Beerli, D. J. Segal, J. D. Flippin, and C. F. Barbas, Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors, J. Biol. Chem, vol.276, pp.29466-29478, 2001.

D. Duan, Q. Li, A. W. Kao, Y. Yue, J. E. Pessin et al., Dynamin is required for recombinant adeno-associated virus type 2 infection, J. Virol, vol.73, pp.10371-10376, 1999.

G. Duchenne, Etude comparée des lésions anatomiques de l'atrophie musculaire graisseuse progressive et de la paralysie générale, 1853.

G. Duchenne, De l'ataxie locomotrice progressive. Arch. Générales Médecine 5 sér, vol.12, pp.417-451, 1858.

G. Duchenne, De la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique, Arch. Générales Médecine, vol.11, issue.5, p.552, 1868.

J. B. Duffy, GAL4 system in Drosophila: a fly geneticist's Swiss army knife, Genes. N. Y. N, vol.34, pp.1-15, 2000.

J. Dunne, A. M. Hanby, R. Poulsom, T. A. Jones, D. Sheer et al., Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule, Genomics, vol.30, pp.207-223, 1995.

R. Dutta and M. Inouye, GHKL, an emergent ATPase/kinase superfamily, Trends Biochem. Sci, vol.25, pp.24-28, 2000.

H. C. Eberl, C. G. Spruijt, C. D. Kelstrup, M. Vermeulen, and M. Mann, A map of general and specialized chromatin readers in mouse tissues generated by label-free interaction proteomics, Mol. Cell, vol.49, pp.368-378, 2013.

A. B. Eberle, L. Stalder, H. Mathys, R. Z. Orozco, and O. Mühlemann, Posttranscriptional gene regulation by spatial rearrangement of the 3' untranslated region, PLoS Biol, vol.6, p.92, 2008.

F. Eckstein, Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?, Antisense Nucleic Acid Drug Dev, vol.10, pp.117-121, 2000.

R. A. Edwards and J. Bryan, Fascins, a family of actin bundling proteins, Cell Motil. Cytoskeleton, vol.32, pp.1-9, 1995.

M. Egholm, O. Buchardt, L. Christensen, C. Behrens, S. M. Freier et al., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules, Nature, vol.365, pp.566-568, 1993.

M. Ehrlich, L. , and M. , Deciphering transcription dysregulation in FSH muscular dystrophy, J. Hum. Genet, vol.57, pp.477-484, 2012.

M. Ehrlich, K. Jackson, K. Tsumagari, P. Camaño, and R. J. Lemmers, Hybridization analysis of D4Z4 repeat arrays linked to FSHD, Chromosoma, vol.116, pp.107-116, 2007.

S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber et al., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, vol.411, pp.494-498, 2001.

R. Elkon, A. P. Ugalde, A. , and R. , Alternative cleavage and polyadenylation: extent, regulation and function, Nat. Rev. Genet, vol.14, pp.496-506, 2013.
DOI : 10.1038/nrg3482

A. E. Emery, The muscular dystrophies, Lancet Lond. Engl, vol.359, pp.687-695, 2002.

D. Escors and K. Breckpot, Lentiviral vectors in gene therapy: their current status and future potential, Arch. Immunol. Ther. Exp. (Warsz.), vol.58, pp.107-119, 2010.

G. J. Farrar, S. Millington-ward, N. Chadderton, P. Humphries, K. et al., Gene-based therapies for dominantly inherited retinopathies, Gene Ther, vol.19, pp.137-144, 2012.

P. M. Faustmann, J. Farahati, B. Rupilius, R. Dux, M. C. Koch et al., Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 singlephoton-emission-computed tomography, J. Neurol. Sci, vol.144, pp.59-63, 1996.

A. P. Feinberg, Phenotypic plasticity and the epigenetics of human disease, Nature, vol.447, pp.433-440, 2007.

Q. Feng, L. Snider, S. Jagannathan, R. Tawil, S. M. Van-der-maarel et al., A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy, 2015.

F. K. Ferrari, T. Samulski, T. Shenk, and R. J. Samulski, Second-strand synthesis is a ratelimiting step for efficient transduction by recombinant adeno-associated virus vectors, J. Virol, vol.70, pp.3227-3234, 1996.

M. Ferreboeuf, V. Mariot, B. Bessières, A. Vasiljevic, T. Attié-bitach et al., DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles, Hum. Mol. Genet, vol.23, pp.171-181, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01907613

M. Ferreboeuf, V. Mariot, D. Furling, G. Butler-browne, V. Mouly et al., Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases, Hum. Mol. Genet, vol.23, pp.4125-4133, 2014.

A. Ferrer, H. Foster, K. E. Wells, G. Dickson, and D. J. Wells, Long-term expression of fulllength human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins, Gene Ther, vol.11, pp.884-893, 2004.

G. Ferri, C. H. Huichalaf, R. Caccia, and D. Gabellini, Direct interplay between two candidate genes in FSHD muscular dystrophy, Hum. Mol. Genet, vol.24, pp.1256-1266, 2015.

W. Filipowicz, S. N. Bhattacharyya, and N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat. Rev. Genet, vol.9, pp.102-114, 2008.

G. N. Filippova, Genetics and epigenetics of the multifunctional protein CTCF, Curr. Top. Dev. Biol, vol.80, pp.337-360, 2008.

L. E. Finlan, D. Sproul, I. Thomson, S. Boyle, E. Kerr et al., Recruitment to the nuclear periphery can alter expression of genes in human cells, PLoS Genet, vol.4, p.1000039, 2008.

J. Finsterer, C. Stöllberger, and G. Meng, Cardiac involvement in facioscapulohumeral muscular dystrophy, Cardiology, vol.103, pp.81-83, 2005.

A. Fiorini, F. Gouveia, S. De, and M. A. Fernandez, Scaffold/Matrix Attachment Regions and intrinsic DNA curvature, Biochem. Biokhimiia, vol.71, pp.481-488, 2006.

A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, vol.391, pp.806-811, 1998.

R. B. Fitzsimons, E. B. Gurwin, and A. C. Bird, Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications, Brain J. Neurol, vol.110, pp.631-648, 1987.

D. R. Flower, The lipocalin protein family: structure and function, Biochem. J, vol.318, pp.1-14, 1996.

V. C. Foletta, L. J. White, A. E. Larsen, B. Léger, and A. P. Russell, The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy, Pflugers Arch, vol.461, pp.325-335, 2011.

D. K. Fox, S. M. Ebert, K. S. Bongers, M. C. Dyle, S. A. Bullard et al., p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization, Am. J. Physiol. Endocrinol. Metab, vol.307, pp.245-261, 2014.

C. Francastel, D. Schübeler, D. I. Martin, and M. Groudine, Nuclear compartmentalization and gene activity, Nat. Rev. Mol. Cell Biol, vol.1, pp.137-143, 2000.

W. R. Frontera and J. Ochala, Skeletal muscle: a brief review of structure and function, Calcif. Tissue Int, vol.96, pp.183-195, 2015.

K. Fukumura, A. Kato, Y. Jin, T. Ideue, T. Hirose et al., Tissue-specific splicing regulator Fox-1 induces exon skipping by interfering E complex formation on the downstream intron of human F1gamma gene, Nucleic Acids Res, vol.35, pp.5303-5311, 2007.

M. Funakoshi, K. Goto, A. , and K. , Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy, Neurology, vol.50, pp.1791-1794, 1998.

A. Furger, A. Schaller, and D. Schümperli, Functional importance of conserved nucleotides at the histone RNA 3' processing site, vol.4, pp.246-256, 1998.

D. Gabellini, M. R. Green, and R. Tupler, Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle, Cell, vol.110, pp.339-348, 2002.

D. Gabellini, G. D'antona, M. Moggio, A. Prelle, C. Zecca et al., Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1, Nature, vol.439, pp.973-977, 2006.

J. Gabriëls, M. C. Beckers, H. Ding, A. De-vriese, S. Plaisance et al., Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element, Gene, vol.236, pp.25-32, 1999.

M. Gaillard, S. Roche, C. Dion, A. Tasmadjian, G. Bouget et al., Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers, Neurology, vol.83, pp.733-742, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01610019

F. Galetta, F. Franzoni, R. Sposito, Y. Plantinga, F. R. Femia et al., Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy, Neuromuscul. Disord. NMD, vol.15, pp.403-408, 2005.

A. Gali?ska-rakoczy, P. Engel, C. Xu, H. Jung, R. Craig et al., Structural basis for the regulation of muscle contraction by troponin and tropomyosin, J. Mol. Biol, vol.379, pp.929-935, 2008.

G. Galli, H. Hofstetter, H. G. Stunnenberg, and M. L. Birnstiel, Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini, Cell, vol.34, pp.823-828, 1983.

G. Galluzzi, G. Deidda, S. Cacurri, L. Colantoni, N. Piazzo et al., Molecular analysis of 4q35 rearrangements in fascioscapulohumeral muscular dystrophy (FSHD): application to family studies for a correct genetic advice and a reliable prenatal diagnosis of the disease, Neuromuscul. Disord. NMD, vol.9, pp.190-198, 1999.

H. H. Gan and K. C. Gunsalus, Assembly and analysis of eukaryotic Argonaute-RNA complexes in microRNA-target recognition, Nucleic Acids Res, vol.43, pp.9613-9625, 2015.

G. Gao, Q. Wang, R. Calcedo, L. Mays, P. Bell et al., Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses, Hum. Gene Ther, vol.20, pp.930-942, 2009.

G. Gao, L. Zhong, and O. Danos, Exploiting natural diversity of AAV for the design of vectors with novel properties, Methods Mol. Biol. Clifton NJ, vol.807, pp.93-118, 2011.

L. García, K. Urbiola, N. Düzgüne?, T. De-ilarduya, and C. , Lipopolyplexes as nanomedicines for therapeutic gene delivery, Methods Enzymol, vol.509, pp.327-338, 2012.

G. Gasiunas, R. Barrangou, P. Horvath, and V. Siksnys, Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.2579-2586, 2012.

S. M. Gasser and U. K. Laemmli, Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster, Cell, vol.46, pp.521-530, 1986.

M. Gaszner and G. Felsenfeld, Insulators: exploiting transcriptional and epigenetic mechanisms, Nat. Rev. Genet, vol.7, pp.703-713, 2006.
DOI : 10.1038/nrg1925

J. R. Gatchel and H. Y. Zoghbi, Diseases of unstable repeat expansion: mechanisms and common principles, Nat. Rev. Genet, vol.6, pp.743-755, 2005.

M. Van-geel, M. C. Dickson, A. F. Beck, D. J. Bolland, R. R. Frants et al., Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin, Genomics, vol.79, pp.210-217, 2002.

J. Gehl, Gene electrotransfer in clinical trials, Methods Mol. Biol. Clifton NJ, vol.1121, pp.241-246, 2014.

T. M. Geiman and K. Muegge, DNA methylation in early development, Mol. Reprod. Dev, vol.77, pp.105-113, 2010.

A. Gendrel, Y. A. Tang, M. Suzuki, J. Godwin, T. B. Nesterova et al., Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes, Mol. Cell. Biol, vol.33, pp.3150-3165, 2013.

L. N. Geng, A. E. Tyler, and S. J. Tapscott, Immunodetection of human double homeobox 4. Hybrid, vol.30, pp.125-130, 2005.

L. N. Geng, Z. Yao, L. Snider, A. P. Fong, J. N. Cech et al., DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy, Dev. Cell, vol.22, pp.38-51, 2012.

P. Genovese, G. Schiroli, G. Escobar, T. Di-tomaso, C. Firrito et al., Targeted genome editing in human repopulating haematopoietic stem cells, Nature, vol.510, pp.235-240, 2014.

S. Giannini, C. Faldini, S. Pagkrati, G. Grandi, V. Digennaro et al., Fixation of Winged Scapula in Facioscapulohumeral Muscular Dystrophy, Clin. Med. Res, vol.5, pp.155-162, 2007.

J. R. Gilbert, J. M. Stajich, M. C. Speer, J. M. Vance, C. S. Stewart et al., Linkage studies in facioscapulohumeral muscular dystrophy (FSHD), Am. J. Hum. Genet, vol.51, pp.424-427, 1992.

J. R. Gilbert, J. M. Stajich, S. Wall, S. C. Carter, H. Qiu et al., Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD), Am. J. Hum. Genet, vol.53, pp.401-408, 1993.

J. Gillis, Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse, Neuromuscul. Disord. NMD, vol.12, issue.1, pp.90-94, 2002.

S. L. Ginn, I. E. Alexander, M. L. Edelstein, M. R. Abedi, and J. Wixon, Gene therapy clinical trials worldwide to 2012 -an update, J. Gene Med, vol.15, pp.65-77, 2013.
DOI : 10.1002/jgm.2698

A. Girod, C. E. Wobus, Z. Zádori, M. Ried, K. Leike et al., The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity, J. Gen. Virol, vol.83, pp.973-978, 2002.

M. G. Goll and T. H. Bestor, Eukaryotic cytosine methyltransferases, Annu. Rev. Biochem, vol.74, pp.481-514, 2005.

W. M. Gombert, S. D. Farris, E. D. Rubio, K. M. Morey-rosler, W. H. Schubach et al., The c-myc Insulator Element and Matrix Attachment Regions Define the c-myc Chromosomal Domain, Mol. Cell. Biol, vol.23, pp.9338-9348, 2003.
DOI : 10.1128/mcb.23.24.9338-9348.2003
URL : https://mcb.asm.org/content/mcb/23/24/9338.full.pdf

M. D. Gomes, S. H. Lecker, R. T. Jagoe, A. Navon, and A. L. Goldberg, Atrogin-1, a musclespecific F-box protein highly expressed during muscle atrophy, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.14440-14445, 2001.
DOI : 10.1073/pnas.251541198
URL : http://europepmc.org/articles/pmc64700?pdf=render

A. M. Gordon, E. Homsher, and M. Regnier, Regulation of contraction in striated muscle, Physiol. Rev, vol.80, pp.853-924, 2000.

C. T. Gordon, S. Xue, G. Yigit, H. Filali, K. Chen et al., De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development, Nat. Genet, vol.49, pp.249-255, 2017.
DOI : 10.1038/ng.3765
URL : https://hal.archives-ouvertes.fr/hal-01617529

B. Gorgonie, S. Andrews, A. Schaller, D. Schümperli, N. K. Gray et al., The stem-loop binding protein stimulates histone translation at an early step in the initiation pathway, RNA, vol.11, pp.1030-1042, 2005.

L. Gorman, D. Suter, V. Emerick, D. Schümperli, and R. Kole, Stable alteration of premRNA splicing patterns by modified U7 small nuclear RNAs, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.4929-4934, 1998.

D. E. Gottschling, O. M. Aparicio, B. L. Billington, and V. A. Zakian, Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription, Cell, vol.63, pp.751-762, 1990.

K. S. Goudy, B. Wang, and R. Tisch, Gene gun-mediated DNA vaccination enhances antigenspecific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice, Clin. Immunol. Orlando Fla, vol.129, pp.49-57, 2008.

A. Goyenvalle, A. Vulin, F. Fougerousse, F. Leturcq, J. Kaplan et al., Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping, Science, vol.306, pp.1796-1799, 2004.

A. Goyenvalle, A. Babbs, G. B. Van-ommen, L. Garcia, and K. E. Davies, Enhanced Exonskipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy, Mol. Ther. J. Am. Soc. Gene Ther, vol.17, pp.1234-1240, 2009.

A. Goyenvalle, J. Wright, A. Babbs, V. Wilkins, L. Garcia et al., Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy, Mol. Ther, vol.20, pp.1212-1221, 2012.
DOI : 10.1038/mt.2012.26
URL : https://doi.org/10.1038/mt.2012.26

S. J. Gratz, A. M. Cummings, J. N. Nguyen, D. C. Hamm, L. K. Donohue et al., Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease, Genetics, vol.194, pp.1029-1035, 2013.

J. C. De-greef, M. Wohlgemuth, O. A. Chan, K. B. Hansson, D. Smeets et al., Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD, Neurology, vol.69, pp.1018-1026, 2007.

J. C. De-greef, R. J. Lemmers, B. G. Van-engelen, S. Sacconi, S. L. Venance et al., Common epigenetic changes of D4Z4 in contractiondependent and contraction-independent FSHD, Hum. Mutat, vol.30, pp.1449-1459, 2009.

J. C. De-greef, R. J. Lemmers, P. Camaño, J. W. Day, S. Sacconi et al., Clinical features of facioscapulohumeral muscular dystrophy 2, Neurology, vol.75, pp.1548-1554, 2010.

P. Gregorevic, M. J. Blankinship, J. M. Allen, R. W. Crawford, L. Meuse et al., Systemic delivery of genes to striated muscles using adenoassociated viral vectors, Nat. Med, vol.10, pp.828-834, 2004.

G. D. Gregory, C. R. Vakoc, T. Rozovskaia, X. Zheng, S. Patel et al., Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes, Mol. Cell. Biol, vol.27, pp.8466-8479, 2007.

C. W. Greider, Telomerase is processive, Mol. Cell. Biol, vol.11, pp.4572-4580, 1991.
DOI : 10.1128/mcb.11.9.4572
URL : https://mcb.asm.org/content/11/9/4572.full.pdf

C. W. Greider and E. H. Blackburn, Identification of a specific telomere terminal transferase activity in Tetrahymena extracts, Cell, vol.43, pp.405-413, 1985.

P. K. Grewal, M. Van-geel, R. R. Frants, P. De-jong, and J. E. Hewitt, Recent amplification of the human FRG1 gene during primate evolution, Gene, vol.227, pp.79-88, 1999.

J. C. Grieger and R. J. Samulski, Adeno-associated virus vectorology, manufacturing, and clinical applications, Methods Enzymol, vol.507, pp.229-254, 2012.

R. C. Griggs, R. Tawil, M. Mcdermott, J. Forrester, D. Figlewicz et al., Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation, Muscle Nerve, 1995.

C. Grimm, B. Stefanovic, and D. Schümperli, The low abundance of U7 snRNA is partly determined by its Sm binding site, EMBO J, vol.12, pp.1229-1238, 1993.

D. Grimm, K. L. Streetz, C. L. Jopling, T. A. Storm, K. Pandey et al., Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways, Nature, vol.441, pp.537-541, 2006.

S. Grosso, R. Mostardini, R. M. Di-bartolo, P. Balestri, and A. Verrotti, Epilepsy, speech delay, and mental retardation in facioscapulohumeral muscular dystrophy, Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc, vol.15, pp.456-460, 2011.

S. Gruber, C. H. Haering, and K. Nasmyth, Chromosomal cohesin forms a ring, Cell, vol.112, pp.765-777, 2003.

P. Grüter, C. Tabernero, C. Von-kobbe, C. Schmitt, C. Saavedra et al., TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus, Mol. Cell, vol.1, pp.649-659, 1998.

L. Guelen, L. Pagie, E. Brasset, W. Meuleman, M. B. Faza et al., Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions, Nature, vol.453, pp.948-951, 2008.

D. C. Guttridge, M. W. Mayo, L. V. Madrid, C. Y. Wang, and A. S. Baldwin, NF-kappaBinduced loss of MyoD messenger RNA: possible role in muscle decay and cachexia, Science, vol.289, pp.2363-2366, 2000.

M. Ha and V. N. Kim, Regulation of microRNA biogenesis, Nat. Rev. Mol. Cell Biol, vol.15, pp.509-524, 2014.

S. Hacein-bey-abina, F. Le-deist, F. Carlier, C. Bouneaud, C. Hue et al., Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy, N. Engl. J. Med, vol.346, pp.1185-1193, 2002.

A. M. Haidet, L. Rizo, C. Handy, P. Umapathi, A. Eagle et al., Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.4318-4322, 2008.

C. L. Halbert, T. A. Standaert, C. B. Wilson, and A. D. Miller, Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure, J. Virol, vol.72, pp.9795-9805, 1998.

T. Hall-pogar, H. Zhang, B. Tian, and C. S. Lutz, Alternative polyadenylation of cyclooxygenase-2, Nucleic Acids Res, vol.33, pp.2565-2579, 2005.

L. A. Hanakahi, L. A. Dempsey, M. Li, and N. Maizels, Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.3605-3610, 1997.

M. L. Hanel, R. D. Wuebbles, and P. L. Jones, Muscular dystrophy candidate gene FRG1 is critical for muscle development, Dev. Dyn. Off. Publ. Am. Assoc. Anat, vol.238, pp.1502-1512, 2009.

M. L. Hanel, C. J. Sun, T. I. Jones, S. W. Long, S. Zanotti et al., Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein, Differ. Res. Biol. Divers, vol.81, pp.107-118, 2011.

Y. Haraguchi, A. B. Chung, A. Torroni, G. Stepien, J. M. Shoffner et al., Genetic mapping of human heart-skeletal muscle adenine nucleotide translocator and its relationship to the facioscapulohumeral muscular dystrophy locus, Genomics, vol.16, pp.479-485, 1993.

A. T. Hark, C. J. Schoenherr, D. J. Katz, R. S. Ingram, J. M. Levorse et al., , 2000.

, CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus, Nature, vol.405, pp.486-489

C. B. Harley, Telomere loss: mitotic clock or genetic time bomb?, Mutat. Res, vol.256, pp.271-282, 1991.
DOI : 10.1016/0921-8734(91)90018-7

C. B. Harley, A. B. Futcher, and C. W. Greider, Telomeres shorten during ageing of human fibroblasts, Nature, vol.345, pp.458-460, 1990.

M. De-haro, I. Al-ramahi, B. De-gouyon, L. Ukani, A. Rosa et al., MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1, Hum. Mol. Genet, vol.15, pp.2138-2145, 2006.

C. Harold, Atlas of genetic diagnosis and counseling, pp.375-380, 2006.

L. M. Hartweck, L. J. Anderson, R. J. Lemmers, A. Dandapat, E. A. Toso et al., A focal domain of extreme demethylation within D4Z4 in FSHD2, Neurology, vol.80, pp.392-399, 2013.

T. Harumoto, M. Ito, Y. Shimada, T. J. Kobayashi, H. R. Ueda et al., , 2010.

, Atypical cadherins Dachsous and Fat control dynamics of noncentrosomal microtubules in planar cell polarity, Dev. Cell, vol.19, pp.389-401

N. D. Hastie, M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green et al., , 1990.

, Telomere reduction in human colorectal carcinoma and with ageing, Nature, vol.346, pp.866-868

B. Hauck, W. Zhao, K. High, X. , and W. , Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction, J. Virol, vol.78, pp.13678-13686, 2004.
DOI : 10.1128/jvi.78.24.13678-13686.2004
URL : https://jvi.asm.org/content/78/24/13678.full.pdf

T. Hayakawa, T. Haraguchi, H. Masumoto, and Y. Hiraoka, Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase, J. Cell Sci, vol.116, pp.3327-3338, 2003.

E. Heitz, Das Heterochromatin der Moose.I, Jahrb Wiss Bot, vol.69, pp.762-818, 1928.

P. L. Hermonat and N. Muzyczka, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells, Proc. Natl. Acad. Sci. U. S. A, vol.81, pp.6466-6470, 1984.

M. J. Herrero, L. Sabater, G. Guenechea, L. Sendra, A. I. Montilla et al., DNA delivery to "ex vivo" human liver segments, Gene Ther, vol.19, pp.504-512, 2012.

H. Herweijer and J. A. Wolff, Progress and prospects: naked DNA gene transfer and therapy, Gene Ther, vol.10, pp.453-458, 2003.
DOI : 10.1038/sj.gt.3301983
URL : https://www.nature.com/articles/3301983.pdf

J. E. Hewitt, R. Lyle, L. N. Clark, E. M. Valleley, T. J. Wright et al., Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy, Hum. Mol. Genet, vol.3, pp.1287-1295, 1994.

R. S. Hikida, Aging changes in satellite cells and their functions, Curr. Aging Sci, vol.4, pp.279-297, 2011.

C. L. Himeda, C. Debarnot, S. Homma, M. L. Beermann, J. B. Miller et al.,

, Myogenic Enhancers Regulate Expression of the Facioscapulohumeral Muscular DystrophyAssociated DUX4 Gene, Mol. Cell. Biol, vol.34, pp.1942-1955

C. L. Himeda, T. I. Jones, and P. L. Jones, Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease, Antioxid. Redox Signal, vol.22, pp.1463-1482, 2015.

C. L. Himeda, T. I. Jones, and P. L. Jones, CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy, Mol. Ther. J. Am. Soc. Gene Ther, vol.24, pp.527-535, 2016.

C. L. Himeda, T. I. Jones, and P. L. Jones, Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies, Trends Pharmacol. Sci, vol.37, pp.249-251, 2016.
DOI : 10.1016/j.tips.2016.02.001
URL : http://europepmc.org/articles/pmc5193161?pdf=render

T. Hirano, At the heart of the chromosome: SMC proteins in action, Nat. Rev. Mol. Cell Biol, vol.7, pp.311-322, 2006.

J. C. Hoeng, J. C. Höng, N. V. Ivanov, P. Hodor, M. Xia et al., Identification of new human cadherin genes using a combination of protein motif search and gene finding methods, J. Mol. Biol, vol.337, pp.307-317, 2004.

M. D. Hoggan, N. R. Blacklow, and W. P. Rowe, Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics, Proc. Natl. Acad. Sci. U. S. A, vol.55, pp.1467-1474, 1966.

P. W. Holland, H. A. Booth, and E. A. Bruford, Classification and nomenclature of all human homeobox genes, BMC Biol, vol.5, p.47, 2007.

N. G. Holmes, Microsatellite markers and the analysis of genetic disease, Br. Vet. J, vol.150, pp.411-421, 1994.

S. Horike, S. Cai, M. Miyano, J. Cheng, and T. Kohwi-shigematsu, Loss of silentchromatin looping and impaired imprinting of DLX5 in Rett syndrome, Nat. Genet, vol.37, pp.31-40, 2005.

R. Hou and N. E. Sibinga, Atrophin Proteins Interact with the Fat1 Cadherin and Regulate Migration and Orientation in Vascular Smooth Muscle Cells, J. Biol. Chem, vol.284, pp.6955-6965, 2009.

P. D. Hsu, E. S. Lander, and F. Zhang, Development and Applications of CRISPR-Cas9 for Genome Engineering, Cell, vol.157, pp.1262-1278, 2014.

B. P. Hughes, Creatine Phosphokinase in Facioscapulohumeral Muscular Dystrophy, Br. Med. J, vol.3, pp.464-465, 1971.
DOI : 10.1136/bmj.3.5772.464
URL : https://www.bmj.com/content/3/5772/464.full.pdf

C. Huichalaf, S. Micheloni, G. Ferri, R. Caccia, and D. Gabellini, DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level, PloS One, vol.9, 2014.

G. Hutvágner and P. D. Zamore, RNAi: nature abhors a double-strand, Curr. Opin. Genet. Dev, vol.12, pp.225-232, 2002.

W. Y. Hwang, Y. Fu, D. Reyon, M. L. Maeder, S. Q. Tsai et al., Efficient genome editing in zebrafish using a CRISPR-Cas system, Nat. Biotechnol, vol.31, pp.227-229, 2013.
DOI : 10.1038/nbt.2501
URL : http://europepmc.org/articles/pmc3686313?pdf=render

R. S. Illingworth and A. P. Bird, CpG islands -"A rough guide, FEBS Lett, vol.583, pp.1713-1720, 2009.
DOI : 10.1016/j.febslet.2009.04.012
URL : https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.febslet.2009.04.012

T. Infante, F. P. Mancini, A. Lanza, A. Soricelli, F. De-nigris et al., Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy, Biochim. Biophys. Acta BBA -Mol. Cell Res, vol.1853, pp.975-986, 2015.

Y. Ishino, H. Shinagawa, K. Makino, M. Amemura, and A. Nakata, Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product, J. Bacteriol, vol.169, pp.5429-5433, 1987.

K. Jabbari and G. Bernardi, Cytosine methylation and CpG, TpG (CpA) and TpA frequencies, Gene, vol.333, pp.143-149, 2004.
DOI : 10.1016/j.gene.2004.02.043

D. A. Jackson, The principles of nuclear structure, Chromosome Res. Int. J. Mol. Supramol. Evol. Asp. Chromosome Biol, vol.11, pp.387-401, 2003.

M. Jacqueline, The identification of Landouzy-Dejerine disease: an investigative history, Neuromuscul. Disord. NMD, vol.21, pp.291-297, 2011.

B. H. Janssen, N. B. Voet, C. I. Nabuurs, H. E. Kan, J. W. De-rooy et al., Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration, PloS One, vol.9, p.85416, 2014.

B. H. Janssen, S. Pillen, N. B. Voet, A. Heerschap, B. G. Van-engelen et al., Quantitative muscle ultrasound versus quantitative MRI in facioscapulohumeral dystrophy, Muscle Nerve, 2014.

M. Jenal, R. Elkon, F. Loayza-puch, G. Van-haaften, U. Kühn et al., The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, vol.149, pp.538-553, 2012.

K. K. Jensen, H. Orum, P. E. Nielsen, and B. Nordén, Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique, Biochemistry (Mosc.), vol.36, pp.5072-5077, 1997.

M. P. Jensen, A. J. Hoffman, B. L. Stoelb, R. T. Abresch, G. T. Carter et al., Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy, Arch. Phys. Med. Rehabil, vol.89, pp.320-328, 2008.

C. Jiang and B. F. Pugh, Nucleosome positioning and gene regulation: advances through genomics, Nat. Rev. Genet, vol.10, pp.161-172, 2009.
DOI : 10.1038/nrg2522
URL : http://europepmc.org/articles/pmc4860946?pdf=render

G. Jiang, F. Yang, P. G. Van-overveld, V. Vedanarayanan, S. Van-der-maarel et al., Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q, Hum. Mol. Genet, vol.12, pp.2909-2921, 2003.

S. Jiao, P. Williams, R. K. Berg, B. A. Hodgeman, L. Liu et al., , 1992.

, Direct gene transfer into nonhuman primate myofibers in vivo, Hum. Gene Ther, vol.3, pp.21-33

M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna et al., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, vol.337, pp.816-821, 2012.

J. S. Johnson and R. J. Samulski, Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus, J. Virol, vol.83, pp.2632-2644, 2009.

P. L. Jones, G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass et al., Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nat. Genet, vol.19, pp.187-191, 1998.

T. I. Jones, J. C. Chen, F. Rahimov, S. Homma, P. Arashiro et al., Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis, Hum. Mol. Genet, vol.21, pp.4419-4430, 2012.

T. I. Jones, C. Yan, P. C. Sapp, D. Mckenna-yasek, P. B. Kang et al., Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing, Clin. Epigenetics, vol.6, p.23, 2014.

T. I. Jones, O. D. King, C. L. Himeda, S. Homma, J. C. Chen et al., Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy, Clin. Epigenetics, vol.7, p.37, 2015.

T. I. Jones, M. Parilla, and P. L. Jones, Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD), PloS One, vol.11, 2016.

J. K. Joung and J. D. Sander, TALENs: a widely applicable technology for targeted genome editing, Nat. Rev. Mol. Cell Biol, vol.14, pp.49-55, 2013.
DOI : 10.1038/nrm3486
URL : http://europepmc.org/articles/pmc3547402?pdf=render

E. Junquera, A. , and E. , Cationic lipids as transfecting agents of DNA in gene therapy, Curr. Top. Med. Chem, vol.14, pp.649-663, 2014.

M. S. Jurica, L. J. Licklider, S. R. Gygi, N. Grigorieff, and M. J. Moore, Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis, vol.8, pp.426-439, 2002.

A. Kaczmarek, S. Schneider, B. Wirth, and M. Riessland, Investigational therapies for the treatment of spinal muscular atrophy, Expert Opin. Investig. Drugs, vol.24, pp.867-881, 2015.

J. Kalkman, M. Schillings, S. P. Van-der-werf, G. Padberg, M. Zwarts et al., Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I, J. Neurol. Neurosurg. Psychiatry, vol.76, pp.1406-1409, 2005.
DOI : 10.1136/jnnp.2004.050005
URL : https://jnnp.bmj.com/content/76/10/1406.full.pdf

J. S. Kalkman, M. L. Schillings, M. J. Zwarts, B. G. Van-engelen, and G. Bleijenberg, The development of a model of fatigue in neuromuscular disorders: a longitudinal study, J. Psychosom. Res, vol.62, pp.571-579, 2007.

J. S. Kalkman, M. J. Zwarts, M. L. Schillings, B. G. Van-engelen, and G. Bleijenberg, , 2008.

, Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue, Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol, vol.29, issue.2, pp.238-240

B. Kalverda, M. D. Röling, and M. Fornerod, Chromatin organization in relation to the nuclear periphery, FEBS Lett, vol.582, pp.2017-2022, 2008.

C. Kanduri, V. Pant, D. Loukinov, E. Pugacheva, C. F. Qi et al., Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive, Curr. Biol. CB, vol.10, pp.853-856, 2000.

Y. Kaneda, Gene therapy: a battle against biological barriers, Curr. Mol. Med, vol.1, pp.493-499, 2001.
DOI : 10.2174/1566524013363519

E. Käs and L. A. Chasin, Anchorage of the Chinese hamster dihydrofolate reductase gene to the nuclear scaffold occurs in an intragenic region, J. Mol. Biol, vol.198, pp.677-692, 1987.

Y. Kashiwakura, K. Tamayose, K. Iwabuchi, Y. Hirai, T. Shimada et al., Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection, J. Virol, vol.79, pp.609-614, 2005.
DOI : 10.1128/jvi.79.1.609-614.2005
URL : https://jvi.asm.org/content/79/1/609.full.pdf

Y. Katoh and M. Katoh, Comparative integromics on FAT1, FAT2, FAT3 and FAT4, Int. J. Mol. Med, vol.18, pp.523-528, 2006.
DOI : 10.3892/ijmm.18.3.523
URL : http://www.spandidos-publications.com/ijmm/18/3/523/download

K. Kawabata, Y. Takakura, and M. Hashida, The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake, Pharm. Res, vol.12, pp.825-830, 1995.

M. Kawamura-saito, Y. Yamazaki, K. Kaneko, N. Kawaguchi, H. Kanda et al., Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation, Hum. Mol. Genet, vol.15, pp.2125-2137, 2006.

N. A. Kearns, H. Pham, B. Tabak, R. M. Genga, N. J. Silverstein et al., Functional annotation of native enhancers with a Cas9-histone demethylase fusion, Nat. Methods, vol.12, pp.401-403, 2015.

M. A. Keaton, C. M. Taylor, R. M. Layer, and A. Dutta, Nuclear Scaffold Attachment Sites within ENCODE Regions Associate with Actively Transcribed Genes, PLoS ONE, vol.6, 2011.

W. Keller, S. Bienroth, K. M. Lang, and G. Christofori, Cleavage and polyadenylation factor CPF specifically interacts with the pre-mRNA 3' processing signal AAUAAA, EMBO J, vol.10, pp.4241-4249, 1991.

R. Kemler, From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion, Trends Genet. TIG, vol.9, pp.317-321, 1993.

C. R. Van-kernebeek, C. G. Seijger, R. J. Goselink, Y. F. Heijdra, and . Van-engelen, Respiratory pattern in a FSHD pediatric population, Respir. Med, 2017.

S. Kervestin and A. Jacobson, NMD: a multifaceted response to premature translational termination, Nat. Rev. Mol. Cell Biol, vol.13, pp.700-712, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00776293

Y. Kerwitz, U. Kühn, H. Lilie, A. Knoth, T. Scheuermann et al., Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA, EMBO J, vol.22, pp.3705-3714, 2003.

J. S. Kim and C. O. Pabo, Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissociation constants, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.2812-2817, 1998.

J. K. Kim, M. Samaranayake, and S. Pradhan, Epigenetic mechanisms in mammals, Cell. Mol. Life Sci. CMLS, vol.66, pp.596-612, 2009.
DOI : 10.1007/s00018-008-8432-4
URL : https://link.springer.com/content/pdf/10.1007%2Fs00018-008-8432-4.pdf

V. N. Kim, J. Han, and M. C. Siomi, Biogenesis of small RNAs in animals, Nat. Rev. Mol. Cell Biol, vol.10, pp.126-139, 2009.

Y. G. Kim, J. Cha, and S. Chandrasegaran, Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain, Proc. Natl. Acad. Sci. U. S. A, vol.93, pp.1156-1160, 1996.
DOI : 10.1073/pnas.93.3.1156
URL : http://www.pnas.org/content/93/3/1156.full.pdf

E. H. Kislauskis and R. H. Singer, Determinants of mRNA localization, Curr. Opin. Cell Biol, vol.4, pp.975-978, 1992.

J. T. Kissel, M. P. Mcdermott, R. Natarajan, J. R. Mendell, S. Pandya et al., Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group, Neurology, vol.50, pp.1402-1406, 1998.
DOI : 10.1212/wnl.50.5.1402

J. T. Kissel, M. P. Mcdermott, J. R. Mendell, W. M. King, S. Pandya et al., Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy, Neurology, vol.57, pp.1434-1440, 2001.

N. P. Kisseljova, P. Dmitriev, A. Katargin, E. Kim, D. Ezerina et al., DNA polymorphism and epigenetic marks modulate the affinity of a scaffold/matrix attachment region to the nuclear matrix, Eur. J. Hum. Genet. EJHG, 2014.

M. Klingenberg, The ADP and ATP transport in mitochondria and its carrier, Biochim. Biophys. Acta, vol.1778, pp.1978-2021, 2008.
DOI : 10.1016/j.bbamem.2008.04.011
URL : https://doi.org/10.1016/j.bbamem.2008.04.011

R. Klooster, K. Straasheijm, B. Shah, J. Sowden, R. Frants et al., Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level, Eur. J. Hum. Genet. EJHG, vol.17, pp.1615-1624, 2009.

R. J. Klose, S. A. Sarraf, L. Schmiedeberg, S. M. Mcdermott, I. Stancheva et al., , 2005.

, DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG, Mol. Cell, vol.19, pp.667-678

M. Koenig, A. H. Beggs, M. Moyer, S. Scherpf, K. Heindrich et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am. J. Hum. Genet, vol.45, pp.498-506, 1989.

C. E. Koering, A. Pollice, M. P. Zibella, S. Bauwens, A. Puisieux et al., Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity, EMBO Rep, vol.3, pp.1055-1061, 2002.
DOI : 10.1093/embo-reports/kvf215
URL : https://hal.archives-ouvertes.fr/hal-01596225

C. Koetsier, Pain related to FSH dystrophy: an underestimated problem? Results of an inquiry in the Netherlands, pp.23-24, 1997.

T. Kohwi-shigematsu and Y. Kohwi, Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer, Biochemistry (Mosc.), vol.29, pp.9551-9560, 1990.
DOI : 10.1021/bi00493a009

R. Kole, A. R. Krainer, and S. Altman, RNA therapeutics: beyond RNA interference and antisense oligonucleotides, Nat. Rev. Drug Discov, vol.11, pp.125-140, 2012.
DOI : 10.1038/nrd3625
URL : http://europepmc.org/articles/pmc4743652?pdf=render

N. G. Kolev and J. A. Steitz, In vivo assembly of functional U7 snRNP requires RNA backbone flexibility within the Sm-binding site, Nat. Struct. Mol. Biol, vol.13, pp.347-353, 2006.

S. Van-koningsbruggen, R. W. Dirks, A. M. Mommaas, J. J. Onderwater, G. Deidda et al., FRG1P is localised in the nucleolus, Cajal bodies, and speckles, J. Med. Genet, vol.41, p.46, 2004.

S. Van-koningsbruggen, K. R. Straasheijm, E. Sterrenburg, N. De-graaf, H. G. Dauwerse et al., FRG1P-mediated aggregation of proteins involved in premRNA processing, Chromosoma, vol.116, pp.53-64, 2007.

E. L. Van-der-kooi, O. J. Vogels, R. J. Van-asseldonk, E. Lindeman, J. C. Hendriks et al., Strength training and albuterol in facioscapulohumeral muscular dystrophy, Neurology, vol.63, pp.702-708, 2004.

E. L. Van-der-kooi, J. S. Kalkman, E. Lindeman, J. C. Hendriks, B. G. Van-engelen et al., Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy, J. Neurol, vol.254, pp.931-940, 2007.

R. D. Kornberg and Y. Lorch, Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome, Cell, vol.98, pp.285-294, 1999.

R. M. Kotin, M. Siniscalco, R. J. Samulski, X. D. Zhu, L. Hunter et al., Site-specific integration by adeno-associated virus, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.2211-2215, 1990.

V. Kowaljow, A. Marcowycz, E. Ansseau, C. B. Conde, S. Sauvage et al., The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein, Neuromuscul. Disord. NMD, vol.17, pp.611-623, 2007.

J. Krol, I. Loedige, and W. Filipowicz, The widespread regulation of microRNA biogenesis, function and decay, Nat. Rev. Genet, vol.11, pp.597-610, 2010.

Y. D. Krom, J. Dumonceaux, K. Mamchaoui, B. Hamer, V. Mariot et al., Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD, Am. J. Pathol, vol.181, pp.1387-1401, 2012.

Y. D. Krom, P. E. Thijssen, J. M. Young, B. Hamer, J. Balog et al., Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD, PLoS Genet, vol.9, p.1003415, 2013.

S. Kuang, K. Kuroda, F. Le-grand, and M. A. Rudnicki, Asymmetric Self-Renewal and Commitment of Satellite Stem Cells in Muscle, Cell, vol.129, pp.999-1010, 2007.

U. Kühn, M. Gündel, A. Knoth, Y. Kerwitz, S. Rüdel et al., Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J. Biol. Chem, vol.284, pp.22803-22814, 2009.

N. Kureishy, V. Sapountzi, S. Prag, N. Anilkumar, A. et al., Fascins, and their roles in cell structure and function, BioEssays News Rev. Mol. Cell. Dev. Biol, vol.24, pp.350-361, 2002.

H. Kuroyanagi, Fox-1 family of RNA-binding proteins, Cell. Mol. Life Sci. CMLS, vol.66, pp.3895-3907, 2009.

A. Kurz, S. Lampel, J. E. Nickolenko, J. Bradl, A. Benner et al., Active and inactive genes localize preferentially in the periphery of chromosome territories, J. Cell Biol, vol.135, pp.1195-1205, 1996.

M. Lachner, D. O'carroll, S. Rea, K. Mechtler, J. et al., Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins, Nature, vol.410, pp.116-120, 2001.

P. Laforêt, C. De-toma, B. Eymard, H. M. Becane, M. Jeanpierre et al., Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy, Neurology, vol.51, pp.1454-1456, 1998.

J. Lagirand-cantaloube, K. Cornille, A. Csibi, S. Batonnet-pichon, M. P. Leibovitch et al., Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo, PLOS ONE, vol.4, p.4973, 2009.

C. Lanctôt, A. Moreau, M. Chamberland, M. L. Tremblay, and J. Drouin, Hindlimb patterning and mandible development require the Ptx1 gene, Dev. Camb. Engl, vol.126, pp.1805-1810, 1999.

E. S. Lander, L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody et al., Initial sequencing and analysis of the human genome, Nature, vol.409, pp.860-921, 2001.

D. Landouzy, De la myopathie atrophique progressive, Rev. Médicale Fr, vol.5, p.81, 1885.

T. De-lange, T-loops and the origin of telomeres, Nat. Rev. Mol. Cell Biol, vol.5, pp.323-329, 2004.

D. Laoudj-chenivesse, G. Carnac, C. Bisbal, G. Hugon, S. Bouillot et al., Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle, J. Mol. Med. Berl. Ger, vol.83, pp.216-224, 2005.

F. Larsen, G. Gundersen, R. Lopez, and H. Prydz, CpG islands as gene markers in the human genome, Genomics, vol.13, pp.1095-1107, 1992.

M. Larsen, S. Rost, N. El-hajj, A. Ferbert, M. Deschauer et al., Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1, Eur. J. Hum. Genet. EJHG, vol.23, pp.808-816, 2015.

R. Lebofsky and A. Bensimon, Single DNA molecule analysis: applications of molecular combing, Brief. Funct. Genomic. Proteomic, vol.1, pp.385-396, 2003.

S. H. Lecker, V. Solomon, W. E. Mitch, and A. L. Goldberg, Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states, J. Nutr, vol.129, pp.227-237, 1999.

G. D. Lee, V. M. Chen, A. C. Barnes, D. R. Goldman, and J. S. Duker, Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy, J. AAPOS Off. Publ. Am. Assoc. Pediatr. Ophthalmol. Strabismus Am. Assoc. Pediatr. Ophthalmol. Strabismus, vol.18, pp.303-305, 2014.

J. H. Lee, K. Goto, K. Sahashi, I. Nonaka, C. Matsuda et al., Cloning and mapping of a very short (10-kb) EcoRI fragment associated with facioscapulohumeral muscular dystrophy (FSHD), Muscle Nerve. Suppl, vol.2, pp.27-31, 1995.

M. S. Lee, G. P. Gippert, K. V. Soman, D. A. Case, and P. E. Wright, Three-dimensional solution structure of a single zinc finger DNA-binding domain, Science, vol.245, pp.635-637, 1989.

R. C. Lee, R. L. Feinbaum, A. , and V. , The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, vol.75, pp.843-854, 1993.
URL : https://hal.archives-ouvertes.fr/in2p3-00597159

Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim et al., The nuclear RNase III Drosha initiates microRNA processing, Nature, vol.425, pp.415-419, 2003.

Y. Lee, M. Kim, J. Han, K. Yeom, S. Lee et al., MicroRNA genes are transcribed by RNA polymerase II, EMBO J, vol.23, pp.4051-4060, 2004.

N. Lehming, A. Le-saux, J. Schüller, and M. Ptashne, Chromatin components as part of a putative transcriptional repressing complex, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.7322-7326, 1998.

B. Lehnertz, Y. Ueda, A. A. Derijck, U. Braunschweig, L. Perez-burgos et al., Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin, Curr. Biol. CB, vol.13, pp.1192-1200, 2003.

A. Leidenroth and J. E. Hewitt, A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene, BMC Evol. Biol, vol.10, p.364, 2010.

A. Leidenroth, J. Clapp, L. M. Mitchell, D. Coneyworth, F. L. Dearden et al., Evolution of DUX gene macrosatellites in placental mammals, Chromosoma, vol.121, pp.489-497, 2012.

A. Lek, F. Rahimov, P. L. Jones, and L. M. Kunkel, Emerging preclinical animal models for FSHD, Trends Mol. Med, vol.21, pp.295-306, 2015.

R. J. Lemmers, Analyzing Copy Number Variation Using Pulsed-Field Gel Electrophoresis: Providing a Genetic Diagnosis for FSHD1, Methods Mol. Biol. Clifton NJ, vol.1492, pp.107-125, 2017.

R. J. Lemmers, S. M. Van-der-maarel, J. C. Van-deutekom, M. J. Van-der-wielen, G. Deidda et al., Inter-and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis, Hum. Mol. Genet, vol.7, pp.1207-1214, 1998.

R. J. Lemmers, M. Wohlgemuth, R. R. Frants, G. W. Padberg, E. Morava et al., Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet, vol.75, pp.1124-1130, 2004.

R. J. Lemmers, P. De-kievit, L. Sandkuijl, G. W. Padberg, G. B. Van-ommen et al., Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere, Nat. Genet, vol.32, pp.235-236, 2002.

R. J. Lemmers, M. Osborn, T. Haaf, M. Rogers, R. R. Frants et al., D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection, Neurology, vol.61, pp.178-183, 2003.

R. J. Lemmers, P. G. Van-overveld, L. A. Sandkuijl, H. Vrieling, G. W. Padberg et al., Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet, vol.75, pp.44-53, 2004.

R. J. Lemmers, M. J. Van-der-wielen, E. Bakker, G. W. Padberg, R. R. Frants et al., Somatic mosaicism in FSHD often goes undetected, Ann. Neurol, vol.55, pp.845-850, 2004.

R. J. Lemmers, M. Wohlgemuth, K. J. Van-der-gaag, . Van-der, P. J. Vliet et al., Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet, vol.81, pp.884-894, 2007.

R. J. Lemmers, . Van-der, P. J. Vliet, R. Klooster, S. Sacconi et al., A unifying genetic model for facioscapulohumeral muscular dystrophy, Science, vol.329, pp.1650-1653, 2010.

R. J. Lemmers, . Van-der, P. J. Vliet, K. J. Van-der-gaag, S. Zuniga et al., Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution, Am. J. Hum. Genet, vol.86, pp.364-377, 2010.

R. J. Lemmers, R. Tawil, L. M. Petek, J. Balog, G. J. Block et al., Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2, Nat. Genet, vol.44, pp.1370-1374, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00770764

R. J. Lemmers, S. Shea, G. W. Padberg, P. W. Lunt, and S. M. Van-der-maarel, Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: workshop 9th, Neuromuscul. Disord. NMD, vol.22, pp.463-470, 2010.

R. J. Lemmers, J. J. Goeman, . Van-der, P. J. Vliet, M. P. Van-nieuwenhuizen et al., Interindividual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2, Hum. Mol. Genet, vol.24, pp.659-669, 2015.

R. J. Lemmers, M. L. Van-den-boogaard, . Van-der, P. J. Vliet, C. M. Donlin-smith et al., Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome. Hum. Mutat, 2015.

G. Leroy, J. T. Weston, B. M. Zee, N. L. Young, M. D. Plazas-mayorca et al., , 2009.

, Heterochromatin Protein 1 Is Extensively Decorated with Histone Code-like Post-translational Modifications, Mol. Cell. Proteomics MCP, vol.8, pp.2432-2442

D. G. Leung, J. A. Carrino, K. R. Wagner, and M. A. Jacobs, Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy, Muscle Nerve, 2015.

S. Levy, G. Sutton, P. C. Ng, L. Feuk, A. L. Halpern et al., The diploid genome sequence of an individual human, PLoS Biol, vol.5, p.254, 2007.

E. Li, Chromatin modification and epigenetic reprogramming in mammalian development, Nat. Rev. Genet, vol.3, pp.662-673, 2002.

S. Li, Electroporation gene therapy: new developments in vivo and in vitro, Curr. Gene Ther, vol.4, pp.309-316, 2004.

E. Li, T. H. Bestor, and R. Jaenisch, Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, vol.69, pp.915-926, 1992.

E. Li, C. Beard, J. , and R. , Role for DNA methylation in genomic imprinting, Nature, vol.366, pp.362-365, 1993.

H. Li, V. Haurigot, Y. Doyon, T. Li, S. Y. Wong et al., In vivo genome editing restores haemostasis in a mouse model of haemophilia, Nature, vol.475, pp.217-221, 2011.

K. Li, C. K. Warner, J. A. Hodge, S. Minoshima, J. Kudoh et al., A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed, J. Biol. Chem, vol.264, pp.13998-14004, 1989.

T. Li, S. Huang, X. Zhao, D. A. Wright, S. Carpenter et al., Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes, Nucleic Acids Res, vol.39, pp.6315-6325, 2011.

Y. Li, J. R. Danzer, P. Alvarez, A. S. Belmont, and L. L. Wallrath, Effects of tethering HP1 to euchromatic regions of the Drosophila genome, Dev. Camb. Engl, vol.130, pp.1817-1824, 2003.

Y. Li, A. B. Korol, T. Fahima, A. Beiles, and E. Nevo, Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review, Mol. Ecol, vol.11, pp.2453-2465, 2002.

Y. S. Li, E. Davidson, C. N. Reid, and A. P. Mchale, Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer, Cancer Lett, vol.273, pp.62-69, 2009.

G. Liang, M. F. Chan, Y. Tomigahara, Y. C. Tsai, F. A. Gonzales et al., Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements, Mol. Cell. Biol, vol.22, pp.480-491, 2002.

M. R. Lieber, Y. Ma, U. Pannicke, and K. Schwarz, Mechanism and regulation of human non-homologous DNA end-joining, Nat. Rev. Mol. Cell Biol, vol.4, pp.712-720, 2003.

I. Liebich, J. Bode, I. Reuter, and E. Wingender, Evaluation of sequence motifs found in scaffold/matrix-attached regions (S/MARs), Nucleic Acids Res, vol.30, pp.3433-3442, 2002.

J. Lim, L. Snider, Z. Yao, R. Tawil, S. M. Van-der-maarel et al., DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD, Hum. Mol. Genet, vol.24, pp.4817-4828, 2015.

D. X. Liu and P. E. Lobie, Transcriptional activation of p53 by Pitx1, Cell Death Differ, vol.14, pp.1893-1907, 2007.

Y. Liu, C. , and X. J. , Adenine Nucleotide Translocase, Mitochondrial Stress, and Degenerative Cell Death, Oxid. Med. Cell. Longev, 2013.

Q. Liu, D. J. Segal, J. B. Ghiara, and C. F. Barbas, Design of polydactyl zinc-finger proteins for unique addressing within complex genomes, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.5525-5530, 1997.

Q. Liu, T. I. Jones, V. W. Tang, W. M. Brieher, and P. L. Jones, Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscleattachment sites, J. Cell Sci, vol.123, pp.1116-1123, 2010.

S. Liu, M. Asparuhova, V. Brondani, I. Ziekau, T. Klimkait et al., Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A, Nucleic Acids Res, vol.32, pp.3752-3759, 2004.

. Lockhart-clarke, Case of musculaire atrophie with disease of the spinal cord, and medulla oblongata, Medico-Chir. Trans, 1867.

M. Logan and C. J. Tabin, Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity, Science, vol.283, pp.1736-1739, 1999.

S. Lomvardas, G. Barnea, D. J. Pisapia, M. Mendelsohn, J. Kirkland et al., Interchromosomal interactions and olfactory receptor choice, Cell, vol.126, pp.403-413, 2006.

C. Lonez, M. Vandenbranden, and J. Ruysschaert, Cationic liposomal lipids: from gene carriers to cell signaling, Prog. Lipid Res, vol.47, pp.340-347, 2008.

C. Long, J. R. Mcanally, J. M. Shelton, A. A. Mireault, R. Bassel-duby et al., Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA, Science, vol.345, pp.1184-1188, 2014.

C. Long, L. Amoasii, A. A. Mireault, J. R. Mcanally, H. Li et al., Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy, Science, vol.351, pp.400-403, 2016.

Z. Lou, J. Wei, H. Riethman, J. A. Baur, R. Voglauer et al., Telomere length regulates ISG15 expression in human cells, Aging, vol.1, pp.608-621, 2009.

R. F. Luco, Q. Pan, K. Tominaga, B. J. Blencowe, O. M. Pereira-smith et al., Regulation of alternative splicing by histone modifications, Science, vol.327, pp.996-1000, 2010.
DOI : 10.1126/science.1184208
URL : http://europepmc.org/articles/pmc2913848?pdf=render

R. F. Luco, M. Allo, I. E. Schor, A. R. Kornblihtt, and T. Misteli, Epigenetics in alternative pre-mRNA splicing, Cell, vol.144, pp.16-26, 2011.
DOI : 10.1016/j.cell.2010.11.056
URL : https://doi.org/10.1016/j.cell.2010.11.056

G. Lucotte, S. Berriche, and M. Fardeau, Linkage analysis of French families with facioscapulohumeral muscular dystrophy, J. Med. Genet, vol.26, pp.485-486, 1989.

S. M. Lukasik, T. Cierpicki, M. Borloz, J. Grembecka, A. Everett et al., , 2006.

, High resolution structure of the HDGF PWWP domain: a potential DNA binding domain, Protein Sci. Publ. Protein Soc, vol.15, pp.314-323

P. W. Lunt and P. S. Harper, Genetic counselling in facioscapulohumeral muscular dystrophy, J. Med. Genet, vol.28, pp.655-664, 1991.

P. W. Lunt, J. G. Noades, M. Upadhyaya, M. Sarfarazi, and P. S. Harper, Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14, J. Neurol. Sci, vol.88, pp.287-292, 1988.

P. W. Lunt, D. A. Compston, and P. S. Harper, Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias, J. Med. Genet, vol.26, pp.755-760, 1989.

P. W. Lunt, P. E. Jardine, M. Koch, J. Maynard, M. Osborn et al., Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy, Muscle Nerve. Suppl, vol.2, pp.103-109, 1995.

P. W. Lunt, P. E. Jardine, M. C. Koch, J. Maynard, M. Osborn et al., Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD), Hum. Mol. Genet, vol.4, pp.951-958, 1995.

C. S. Lutz and A. Moreira, Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression, Wiley Interdiscip. Rev. RNA, vol.2, pp.23-31, 2011.

K. L. Lutz, L. Holte, S. A. Kliethermes, C. Stephan, and K. D. Mathews, Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy, Neurology, vol.81, pp.1374-1377, 2013.

R. Lyle, T. J. Wright, L. N. Clark, and J. E. Hewitt, The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes, Genomics, vol.28, pp.389-397, 1995.

W. Ma, Y. Lin, W. Xuan, P. L. Iversen, L. J. Smith et al., Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs, Oncogene, vol.31, pp.1024-1033, 2012.

S. M. Van-der-maarel, G. Deidda, R. J. Lemmers, P. G. Van-overveld, M. Van-der-wielen et al., De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10, Am. J. Hum. Genet, vol.66, pp.26-35, 2000.

V. Macaione, M. Aguennouz, C. Rodolico, A. Mazzeo, A. Patti et al., RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy, Acta Neurol. Scand, vol.115, pp.115-121, 2007.

C. C. Macdonald, J. Wilusz, and T. Shenk, The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location, Mol. Cell. Biol, vol.14, pp.6647-6654, 1994.

M. M. Mahfouz, L. Li, M. Shamimuzzaman, A. Wibowo, X. Fang et al., De novoengineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.2623-2628, 2011.

P. A. Mahoney, U. Weber, P. Onofrechuk, H. Biessmann, P. J. Bryant et al., The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily, Cell, vol.67, pp.853-868, 1991.

A. N. Mak, .. Bradley, P. Cernadas, R. A. Bogdanove, A. J. Stoddard et al., The crystal structure of TAL effector PthXo1 bound to its DNA target, Science, vol.335, pp.716-719, 2012.

E. M. Makarov, O. V. Makarova, H. Urlaub, M. Gentzel, C. L. Will et al., Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome, Science, vol.298, pp.2205-2208, 2002.

A. Malhas, C. F. Lee, R. Sanders, N. J. Saunders, and D. J. Vaux, Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression, J. Cell Biol, vol.176, pp.593-603, 2007.

K. Mamchaoui, C. Trollet, A. Bigot, E. Negroni, S. Chaouch et al., Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders, Skelet. Muscle, vol.1, p.34, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00651121

M. A. Mandegar, N. Huebsch, E. B. Frolov, E. Shin, A. Truong et al., CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs, Cell Stem Cell, vol.18, pp.541-553, 2016.

C. R. Mandel, Y. Bai, and L. Tong, Protein factors in pre-mRNA 3'-end processing, Cell. Mol. Life Sci. CMLS, vol.65, pp.1099-1122, 2008.

D. A. Mangus, M. C. Evans, and A. Jacobson, Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression, Genome Biol, vol.4, p.223, 2003.

W. C. Manning, S. Zhou, M. P. Bland, J. A. Escobedo, and V. Dwarki, Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors, Hum. Gene Ther, vol.9, pp.477-485, 1998.

R. Manservigi, R. Argnani, and P. Marconi, HSV Recombinant Vectors for Gene Therapy, Open Virol. J, vol.4, pp.123-156, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00144430

A. Marcil, É. Dumontier, M. Chamberland, S. A. Camper, and J. Drouin, Pitx1 and Pitx2 are required for development of hindlimb buds, Development, vol.130, pp.45-55, 2003.

R. Margueron and D. Reinberg, The Polycomb complex PRC2 and its mark in life, Nature, vol.469, pp.343-349, 2011.

V. Mariot, S. Roche, C. Hourdé, D. Portilho, S. Sacconi et al., Correlation between low FAT1 expression and early affected muscle in FSHD, Ann. Neurol, 2015.

W. F. Marshall, Gene expression and nuclear architecture during development and differentiation, Mech. Dev, vol.120, pp.1217-1230, 2003.

A. Marsollier, L. Ciszewski, V. Mariot, L. Popplewell, T. Voit et al., Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach, Hum. Mol. Genet, vol.25, pp.1468-1478, 2016.

L. Martineau, M. A. Horan, N. J. Rothwell, and R. A. Little, Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men, Clin. Sci. Lond. Engl, vol.83, pp.615-621, 1979.

P. S. Masny, U. Bengtsson, S. Chung, J. H. Martin, B. Van-engelen et al., Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?, Hum. Mol. Genet, vol.13, pp.1857-1871, 2004.

P. S. Masny, O. Y. Chan, J. C. De-greef, U. Bengtsson, M. Ehrlich et al., Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei, Eur. J. Hum. Genet. EJHG, vol.18, pp.448-456, 2010.

K. D. Mathews, K. A. Mills, E. P. Bosch, V. V. Ionasescu, K. R. Wiles et al., Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35, Am. J. Hum. Genet, vol.51, pp.428-431, 1992.

J. Mátrai, M. K. Chuah, and T. Vandendriessche, Preclinical and clinical progress in hemophilia gene therapy, Curr. Opin. Hematol, vol.17, pp.387-392, 2010.

T. Matsumura, K. Goto, G. Yamanaka, J. H. Lee, C. Zhang et al., , 2002.

, Chromosome 4q;10q translocations; comparison with different ethnic populations and FSHD patients, BMC Neurol, vol.2, p.7

A. Mattout-drubezki and Y. Gruenbaum, Dynamic interactions of nuclear lamina proteins with chromatin and transcriptional machinery, Cell. Mol. Life Sci. CMLS, vol.60, pp.2053-2063, 2003.

A. Mauro, Satellite cell of skeletal muscle fibers, J. Biophys. Biochem. Cytol, vol.9, pp.493-495, 1961.

L. E. Mays, L. H. Vandenberghe, R. Xiao, P. Bell, H. Nam et al., Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins, J. Immunol. Baltim. Md, vol.182, pp.6051-6060, 1950.

J. L. Mcbride, R. L. Boudreau, S. Q. Harper, P. D. Staber, A. M. Monteys et al., Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.5868-5873, 2008.

S. J. Mccready, A. Akrigg, and P. R. Cook, Electron-microscopy of intact nuclear DNA from human cells, J. Cell Sci, vol.39, pp.53-62, 1979.

A. E. Mckee, E. Minet, C. Stern, S. Riahi, C. D. Stiles et al., A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain, BMC Dev. Biol, vol.5, p.14, 2005.

L. K. Medina-kauwe, J. Xie, and S. Hamm-alvarez, Intracellular trafficking of nonviral vectors, Gene Ther, vol.12, pp.1734-1751, 2005.

H. A. Meijer, E. M. Smith, and M. Bushell, Regulation of miRNA strand selection: follow the leader?, Biochem. Soc. Trans, vol.42, pp.1135-1140, 2014.

G. Meister, Argonaute proteins: functional insights and emerging roles, Nat. Rev. Genet, vol.14, pp.447-459, 2013.

D. P. Melters, J. Nye, H. Zhao, and Y. Dalal, Chromatin Dynamics in Vivo: A Game of Musical Chairs, Genes, vol.6, pp.751-776, 2015.

J. Mendell, N. Goemans, L. Rodino-klapac, Z. Sahenk, L. Lowes et al., Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Clinical Update and Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) (S28.001), Neurology, vol.86, 2016.

J. R. Mendell, Z. Sahenk, V. Malik, A. M. Gomez, K. M. Flanigan et al., A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy, Mol. Ther. J. Am. Soc. Gene Ther, vol.23, pp.192-201, 2015.

R. Meneveri, A. Agresti, A. Marozzi, S. Saccone, M. Rocchi et al., Molecular organization and chromosomal location of human GC-rich heterochromatic blocks, Gene, vol.123, pp.227-234, 1993.

J. Meyne, R. L. Ratliff, and R. K. Moyzis, Conservation of the human telomere sequence (TTAGGG)n among vertebrates, Proc. Natl. Acad. Sci. U. S. A, vol.86, pp.7049-7053, 1989.

P. Midoux, G. Breuzard, J. P. Gomez, and C. Pichon, Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes, Curr. Gene Ther, vol.8, pp.335-352, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00518197

N. Miller, Glybera and the future of gene therapy in the European Union, Nat. Rev. Drug Discov, vol.11, p.419, 2012.

J. Miller, A. D. Mclachlan, and A. Klug, Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes, EMBO J, vol.4, pp.1609-1614, 1985.

J. C. Miller, S. Tan, G. Qiao, K. A. Barlow, J. Wang et al., A TALE nuclease architecture for efficient genome editing, Nat. Biotechnol, vol.29, pp.143-148, 2011.

S. Millevoi and S. Vagner, Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation, Nucleic Acids Res, vol.38, pp.2757-2774, 2010.

K. A. Mills, K. H. Buetow, Y. Xu, T. M. Ritty, K. D. Mathews et al., Genetic and physical mapping on chromosome 4 narrows the localization of the gene for facioscapulohumeral muscular dystrophy (FSHD), Am. J. Hum. Genet, vol.51, pp.432-439, 1992.

E. Minc, J. C. Courvalin, and B. Buendia, HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes, Cytogenet. Cell Genet, vol.90, pp.279-284, 2000.

F. Mingozzi and K. A. High, Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges, Nat. Rev. Genet, vol.12, pp.341-355, 2011.

F. Mingozzi and K. A. High, Immune responses to AAV vectors: overcoming barriers to successful gene therapy, Blood, vol.122, pp.23-36, 2013.

F. Mingozzi, M. V. Maus, D. J. Hui, D. E. Sabatino, S. L. Murphy et al., CD8(+) T-cell responses to adeno-associated virus capsid in humans, Nat. Med, vol.13, pp.419-422, 2007.

J. Mirkovitch, M. E. Mirault, and U. K. Laemmli, Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold, Cell, vol.39, pp.223-232, 1984.

C. Mitrpant, P. Porensky, H. Zhou, L. Price, F. Muntoni et al., Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy, PloS One, vol.8, 2013.

H. Mitsuhashi, S. Mitsuhashi, T. Lynn-jones, G. Kawahara, and L. M. Kunkel, Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy, Hum. Mol. Genet, vol.22, pp.568-577, 2013.

S. Mitsuhashi, S. E. Boyden, E. A. Estrella, T. I. Jones, F. Rahimov et al., Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2, Neuromuscul. Disord. NMD, vol.23, pp.975-980, 2013.

K. Mitsui, D. Nakajima, O. Ohara, and M. Nakayama, Mammalian fat3: a large protein that contains multiple cadherin and EGF-like motifs, Biochem. Biophys. Res. Commun, vol.290, pp.1260-1266, 2002.

K. Miura, T. Kumagai, A. Matsumoto, E. Iriyama, K. Watanabe et al., Two cases of chromosome 4q35-linked early onset facioscapulohumeral muscular dystrophy with mental retardation and epilepsy, Neuropediatrics, vol.29, pp.239-241, 1998.